





















































 DEDICATION  ...............................................................................................................................................ii  ACKNOWLEDGEMENTS......................................................................................................................... iii  LIST OF TABLES ......................................................................................................................................viii  LIST OF FIGURES .......................................................................................................................................ix  Chapter   I. INTRODUCTION.................................................................................................................................... 1    Introduction  ................................................................................................................................1   The cell cycle............................................................................................................................... 2   Cell‐cycle control........................................................................................................................4   The Anaphase Promoting Complex ...................................................................................6   DNA damage response ............................................................................................................8   Chromosome modification  ...................................................................................................8   Autosomal Recessive Primary Microcephaly .............................................................10   Microcephalin...........................................................................................................................12   Evolutionary of MCPH genes.............................................................................................  15   Early Drosophila embryogenesis....................................................................................  16   The Xenopus laevis model system...................................................................................  17    II.  DEVELOPMENTAL REQUIREMENT FOR MCPH1 IN THE EARLY    DROSOPHILA EMBRYO ............................................................................................................. 18      INTRODUCTION  ..................................................................................................................... 18      METHODS................................................................................................................................... 21       Drosophila stocks .................................................................................................... 21     Identification of new alleles of cell‐cycle regulators  ............................... 22     Quantification of embryonic hatch rates.......................................................  22     Genetic and molecular mapping of awol.........................................................  22     Generation of mcph1 excision line...................................................................  23     Embryo fixation, staining and microscopy ................................................... 24     Embryo squashes and quantification of DNA bridging ........................... 25     Live embryo imaging  ............................................................................................. 25     mcph1 cDNA clones and transgenes  ............................................................... 26 
    Polyclonal antibodies against MCPH1............................................................  26 
  vi 
    Protein extracts and immunoblots  .................................................................. 26     DNA damage response assays  ........................................................................... 27     Adult brain immunostaining  .............................................................................. 28     RESULTS ..................................................................................................................................... 28     Screen for Drosophila cell‐cycle mutants identifies absent without 
     leave (awol) ................................................................................................................ 28     awol encodes the Drosophila homolog of MCPH1  ......................................33     MCPH1 isoforms differ in expression pattern and BRCT domain      content  ......................................................................................................................... 35     MCPH1 is a nuclear protein  ................................................................................ 39     Mitotic arrest in mcph1 syncytial embryos is a consequence of Chk2      activation ....................................................................................................................  41     mcph1 syncytial embryos exhibit a high frequency of chromatin      bridging  ....................................................................................................................... 45     mcph1 is not required for the DNA checkpoint in Drosophila ..............48 
    mcph1 cooperates with mei­41 and grp to regulate syncytial      divisions  ...................................................................................................................... 51     mcph1 males exhibit defects in adult brain structure ............................. 54     DISCUSSION .............................................................................................................................. 57  III.  REGULATION OF HUMAN AND DROSOPHILA MCPH1 BY THE ANAPHASE PROMOTING COMPLEX ............................................................................................................. 62      INTRODUCTION....................................................................................................................... 62     METHODS................................................................................................................................... 64       Drosophila stocks..................................................................................................... 64       Drosophila mcph1 cDNA clones and transgenes ........................................ 64       Polyclonal antibodies against Drosophila MCPH1..................................... 64     Drosophila IVEC screen for APC substrates and APC‐mediated        degradation assays ..................................................................................................65       Subcellular localization of APC substrates in mammalian cells...........66       Drosophila protein extracts and immunoblots ...........................................66       Quantification of embryonic hatch rates........................................................67       Cell culture extracts and immunoblots...........................................................67       Cell synchronization ............................................................................................... 67       In vivo ubiquitylation assay .................................................................................68       Capped RNA synthesis ...........................................................................................69       Xenopus embryo injections .................................................................................69       Live analysis of Xenopus embryos....................................................................70       Immunostaining of Xenopus embryos ............................................................70     RESULTS ..................................................................................................................................... 71       A screen for substrates of the Anaphase‐Promoting Complex        identifies Drosophila MCPH1.............................................................................. 71       MCPH1‐B contains a functional  D box ........................................................... 74       Drosophila MCPH1‐B is an in vivo substrate of the Anaphase       Promoting Complex................................................................................................. 76 
  vii 




 Table:  Page: 2.1  New alleles of known cell‐cycle regulators in Drosophila........................................30 2.2  Mitotic spindle defects in mcph1 embryos and suppression by mnk.................32 2.3  Effects of maternal overexpression of transgenic mcph1 on development    of awol or wild‐type embryos ............................................................................................. 36  3.1  New APC substrates from Drosophila IVEC screen ................................................... 73 4.1  MCPH1 interactors................................................................................................................ 100 
  ix 
LIST OF FIGURES 
 Figure:  Page: 1.1  Variations of the cell cycle during Drosophila development.....................................3 1.2  The Anaphase Promoting Complex ........................................................................................7 1.3  Comparison of brain size in subjects with or without primary    microcephaly ............................................................................................................................. 11 2.1  The awol phenotype ................................................................................................................ 31 2.2  mcph1 is the awol gene .......................................................................................................... 34 2.3  Developmental expression of alternate MCPH1 isoforms ...................................... 37 2.4  MCPH1 is a nuclear protein.................................................................................................. 40 2.5  Decreased γ‐tubulin staining of centrosomes in mcph1 embryos....................... 43 2.6  Suppression of mcph1 by Chk2 (mnk).............................................................................. 44 2.7  Chromatin bridging in mcph1 embryos .......................................................................... 47 2.8  mcph1 larvae have intact DNA checkpoints and normal sensitivity to    DNA‐damaging agents ............................................................................................................ 49 2.9  Intact DNA‐replication checkpoint and normal Cyclin B levels in  
  mcph1 embryos ......................................................................................................................... 52 2.10  mcph1 cooperates with mei­41 and grp in the early embryo ................................ 53 2.11  Defects in male mcph1 brains.............................................................................................. 56 3.1  Drosophila MCPH1‐B is an APC substrate ..................................................................... 72 3.2  Identification of the critical destruction box within MCPH1‐B ............................ 75 3.3  Drosophila MCPH1‐B is an in vivo APC substrate....................................................... 77 3.4  Human MCPH1 is an APC substrate.................................................................................. 81 3.5  MCPH1‐injected Xenopus embryos exhibit cell‐cycle defects............................... 84 
  x 







Introduction   DNA  is  the  code  of  life  responsible  for  the  production  of  all  proteins,  from bacteria to the animal kingdom.  The entire genome is made up of a code consisting of  only  four different  nucleotides,  the  basic  building blocks  of DNA  structure,  and gives rise to genes and regulatory sequences that determine the proteins to be made within  the  cell.    The  genes  are  transcribed  into  messenger  RNA  that,  when  fully processed, can be  translated  into proteins, which compose  the majority of cellular contents  and  account  for  enzymatic  reactions  within  the  cell.    Genetic  mutations affecting  protein  structure  or  production,  and  that  result  in  greater  fitness  and overall cell survival, have been occurring since the first cell was formed billions of years  ago.    Spontaneous mutations  that do not  lead  to positive  changes,  however, are  responsible  for  a  vast  number  of  diseases,  including  cancer,  an  out‐of‐control growth of cells that most often arises from genetic instability and failure to properly repair DNA.     It  is  here  in  this  dissertation  that  I  present  my  research,  all  aimed  to understand  the  role  of  MCPH1,  a  protein  required  for  genomic  stability  in multicellular organisms.  I begin by describing the consequence of a null mutation of 
mcph1 and the genomic catastrophe that occurs in developing Drosophila embryos.  Next,  I  present  the  cell‐cycle  regulation  of  MCPH1  by  the  Anaphase  Promoting 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Complex,  a  multi‐subunit  structure  that  targets  proteins  for  ubiquitin‐mediated degradation.   Finally, I present a screen for binding partners of Drosophila MCPH1 in an effort to place the protein within a molecular framework.  
The cell cycle 




Figure  1.1.  Variations  of  the  cell  cycle  during  Drosophila  development.  Cartoon depicting the types of cell cycles found in Drosophila. 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Briefly, prior to replicating DNA during S phase, a DNA damage checkpoint ensures the cell will not begin replicating damaged chromosomes.  Checkpoints at the G2/M transition  also  ensure  chromosomes  are  not  damaged  and  that  the  cells  have duplicated other components prior to the start of cell division.     Variations  of  the  canonical  cell  cycles  exist  depending  on  the  needs  of particular types of cells (Lee and Orr‐Weaver, 2003).  For example, during meiosis, germ  cells  replicate  chromosomes  once  producing  4n  copies.    This  is  followed  by two divisions, meiosis  I  and meiosis  II, with  the  result  of  a  single  chromosome  in each  germ  cell  (Figure  1.1).    Expedited  cycles  lacking  gap  phases  exist  for  some developing  organisms  to  ensure  survival  (Figure  1.1).    Other  cells  may  require repeated  rounds  of  replication  without  division,  also  known  as  endocycles,  and function  as  transcriptional  powerhouses  to  provide  mRNAs  and  proteins  for neighboring  cells  (Figure  1.1).    This  is  the  case  during  larval  development  in Drosophila as well as in oocyte development.  
Cell­cycle control   Progression through the cell cycle  is controlled by Cyclin Dependent Kinase or Cdk activity.  In Drosophila and vertebrates, four Cdk complexes exist which are important for cell cycle control and are activated when bound to a Cyclin (Morgan, 1997).  Cdk2/Cyclin E promotes entry into S phase while Cdk2/Cyclin A is required for  its  completion.    Additionally,  Cdk1/Cyclin  A  activity  is  required  for  entry  into mitosis,  promoting  activation  of  Cdk1/Cyclin  B  which  is  required  during  early 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2007).    Other  motifs  have  been  recognized,  including  the  A‐box  and  the  O‐box, though exactly how the APC recognizes its substrates remains a mystery (Simpson‐Lavy  et  al.,  2010).    At  the  end  of  G1,  the  APC  itself  is  targeted  for  destruction, ensuring that cyclin levels can rise again to promote S phase.  
DNA damage response   DNA damage such as double‐stranded breaks may lead to genomic instability if not  repaired.    Damage  may  arise  spontaneously  during  cellular  processes  like replication but may also occur  in  the presence of DNA damaging  agents  like ultra violet  light  or  X‐rays  (Karagiannis  and  El‐Osta,  2004).    The  classic  checkpoint associated with DNA damage  and  incomplete DNA  replication  occurs  at  the G2‐M transition  in many  cell  types  (including  Drosophila,  mammalian  cells,  and  fission yeast) as a mechanism to ensure that the correct genetic material is transmitted to daughter cells during mitosis (for review, see Chen and Sanchez, 2004).  When DNA damage or incomplete replication is sensed in a cell, the ATM (Ataxia telengiectasia mutated) and ATR (ATM and Rad3‐related) kinases are activated and phosphorylate Chk1 and Chk2, which then phosphorylates downstream targets to cause a cell cycle arrest and activate repair.  One such target is Cdc25, the phosphatase that removes the inhibitory phosphate group from Cdk1 in order for cells to enter into mitosis.  
 
Chromatin modifications   Within  the nucleus, DNA is packaged  into chromatin  fibers with  the help of histone octomer.   Two units each of Histones H3, H4, H2A, and H2B make up  this 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 Microcephaly  describes  the  condition  in  which  an  individual’s  head circumference is four or more standard deviations below the mean (for review, see Kumar et al., 2002; Woods, 2004).   Head size  is an  indicator of brain size because outward  pressure  of  the  developing  brain  causes  cranial  vault  enlargement.  Primary  microcephaly  (occurring  by  32  weeks  of  gestation)  is  likely  caused  by increased  apoptosis  during  neuronal  development  or  decreased  production  of neurons whereas secondary microcephaly (occurring after birth) is due to reduced dendritic  connections  (Woods,  2004).    As  a  result,  individuals  with  primary microcephaly are born with brains that are architecturally normal but lack several layers of  the cerebral  cortex  (Figure 1.3). Causes of primary microcephaly  include environmental (e.g. infection or maternal alcohol consumption) and genetic factors.  To  date,  seven  loci  have  been  linked  to  autosomal  recessive  forms  of  primary microcephaly  (MCPH), and  five have been mapped  to genes  (Microcephalin, ASPM, 
Cdk5rap2, Cenpj, and STIL).  All except STIL have roles or hypothesized roles in the cell cycle and homologs in Drosophila.   




Figure  1.3.  Comparison  of  brain  size  in  subjects  with  or  without  primary 
microcephaly.   MRI  reveals  brain  that  is  much  smaller  in  age‐  and  sex‐matched microcephalic patient. Adapted from Ponting  and Jackson (2005). 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centrosomin, which  interacts with  the  γ‐tubulin  ring  complex  (γTuRC)  responsible for microtubule  nucleation  during mitosis  (Li  and  Kaufman,  1996; Megraw  et  al., 1999;  Terada  et  al.,  2003).    CENPJ  also  associates  with  γTuRC  and  inhibits microtubule assembly (Hung et al., 2004).  Dsas­4, the Drosophila homolog of CENPJ, is  required  for  centrosome  integrity.    Dsas­4  mutants  lack  centrioles  and  cilia, displaying  defects  in  their  sensory  neurons  (Basto  et  al.,  2006).    Furthermore, approximately  30%  of  the  neuronal  precursor  asymmetric  divisions  of  the developing  Drosophila  brain  fail.    Finally,  the  zebrafish  homolog  of  human  STIL encodes  a  centrosomal protein  required  for proper  spindle  formation  (Pfaff  et  al., 2007).  
Microcephalin   Members  of  consanguineous  families  in  northern  Pakistan  with  primary microcephaly  were  found  to  have  a  nonsense  mutation  in  the microcephalin,  or 
MCPH1, gene resulting in a severe truncation near the amino terminus of the protein (Jackson et al., 2002; Woods et al., 2005).   MCPH1 contains three BRCT (BRCA1 C‐terminal) domains: one N‐terminal and two C‐terminal.   BRCT domains, which are 80‐100 amino acids in length, can bind to double‐stranded DNA (dsDNA) breaks and form  homo‐  or  hetero‐dimers  (Huyton  et  al.,  2000).    It  was  reported  that  BRCT domains preferentially bind to phosphorylated targets of ATM/ATR kinases (Manke et al.,  2003).   Many BRCT domain‐containing proteins are known  to participate  in the DNA damage response.  For example, XRCC1, a DNA repair protein, has a BRCT domain  that  interacts  with  DNA  ligase  III  (Taylor  et  al.,  1998),  and  BRCA1  has 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tandem  BRCT motifs  at  its  carboxyl  terminus  that  bind  to  a  DNA  repair  helicase, BACH1  (Yu  et  al.,  2003).    Thus,  MCPH1  is  hypothesized  to  play  a  cell  cycle  role because it contains BRCT domains.     Several groups have now discovered that MCPH1 plays a role in the response to DNA damage.  Depletion of MCPH1 in HEK293 or U2OS cells by RNA interference was  reported  to  reduce  levels  of BRCA1 and Checkpoint  kinase 1  (Chk1),  thereby affecting  intra‐S‐phase  and  G2‐M  checkpoints  (Xu  et  al.,  2004;  Lin  et  al.,  2005).  MCPH1  was  further  shown  to  participate  within  the  response  to  DNA  damage functioning  directly  in  the  ATR/Chk1  pathway;  however,  reports  conflict  on whether MCPH1  functions  upstream  of  ATR  or  downstream  of  Chk1.    One  study, which  suggested  a  downstream  role,  determined  that MCPH1  could  bind  Chk1  in 
vitro,  inhibit Cdc25 activity, and prevent entry  into mitosis  (Alderton et al., 2006).  Additionally,  MCPH1  was  found  to  promote  inhibitory  phosphorylation  of  Cdk1 independently of ATR and Chk1 (Alderton et al., 2006).   In  contrast,  several  groups  have  discovered  that MCPH1  functions  early  in the response to DNA damage, localizing to sites of double stranded DNA breaks by binding to phospho‐H2AX (Wood et al., 2007;  Jeffers et al., 2008).   Once recruited, MCPH1 further mediates the damage response.  First, MCPH1 binds RPA that in turn recruits ATR‐ATRIP, promoting an ATR damage response cascade (Rai et al., 2006).  Additionally, MCPH1 brings  in the BRCA2‐Rad51 complex to  initiate repair (Wu et al., 2009).  The ability of MCPH1 to localize to dsDNA breaks or irradiation‐induced foci is dependent upon its C‐terminal BRCT domains (Wood et al., 2007; Jeffers et al., 2008).    MCPH1  also  acts  as  a  transcriptional  regulator  of  E2F1,  promoting  the 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transcription  of many DNA  response  and  repair  genes  such  as  Chk1,  BRCA1,  p73, and Rad51 (Yang et al., 2008).   Patients  homozygous  for  a  severely  truncating mutation  in MCPH1  exhibit premature  chromosome  condensation  (characterized  by  an  abnormally  high percentage  of  lymphocytes  in  a  prophase‐like  state),  which  suggests  a  role  for Microcephalin in the control of cell‐cycle timing (Trimborn et al., 2004).  In addition to condensing too soon, chromosomes also fail to decondense in a timely manner at the  end  of mitosis  (Trimborn  et  al.,  2004).    Further  studies  revealed  that MCPH1 negatively regulates  the Condensin  II complex  to prevent premature condensation (Trimborn  et  al.,  2006). Whereas  the  C‐terminal  BRCT domains were  found  to  be important  for  the  DNA  damage  response  role  of  MCPH1,  the  N‐terminal  BRCT domain is required to prevent the condensation defect (Wood et al., 2008; Richards et al., 2009). Thus, MCPH1 appears to have another cell‐cycle role distinct from its participation  in  the  DNA  damage  response.    The  capacity  of  MCPH1  to  promote changes in chromatin structure, however, has been linked to its capacity to promote DNA  repair.    MCPH1,  together  with  the  Condensin  II  complex,  is  required  for homologous  recombination  repair  (Wood  et  al.,  2008).    In  addition, MCPH1 binds directly with  the  ATP‐dependent  chromatin  remodeling  complex,  SWI‐SNF,  in  the presence of DNA damage (Peng et al., 2009).   This interaction promotes chromatin relaxation and provides  increased accessibility  for repair enzymes to the damaged DNA.   Taken together, these data suggest MCPH1 functions somewhat as a cellular middleman, linking the state of the chromatin to DNA repair. 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 MCPH1 has  been  observed  to  have  a  role  in  telomere maintenance  as well (Lin and Elledge, 2003; Kim et al., 2009).  In addition to the observations of nuclear MCPH1, several groups have localized MCPH1 to centrosomes  (Zhong et al., 2006; Brunk  et  al.,  2007;  Jeffers  et  al.,  2008;  Tibelius  et  al.,  2009).      In  one  study, centrosomal  MCPH1  is  required  to  recruit  Chk1  to  prevent  early  Cdk1/Cyclin  B activation (Tibelius et al., 2009).     One of  the hallmarks of  cancer  is genomic  instability, and MCPH1 has been found  to  be  downregulated  in  several  human  cancer  cell  lines  (Rai  et  al.,  2006).  Interestingly,  it  has  been  suggested  that  too  much  MCPH1  also  leads  to  a developmental defect in the form of autism (Glancy et al., 2008; Ozgen et al., 2009).  Recently, the first MCPH1 mouse models were described and confirmed results from previous studies.  In one study, an MCPH1 knockout mouse was created, resulting in severe DNA repair defects (Liang et al., 2010).   The mice were retarded  in growth and sterile.   A second study established a hypomorphic model with defects only in chromosome condensation (Trimborn et al., 2010).     
 
Evolution of MCPH genes 
  Recent  reports  indicate  that microcephalin  and ASPM,  another MCPH  gene, are among the most rapidly evolving genes in higher organisms (Evans et al., 2004; Ponting  and  Jackson,  2005; Wang  and  Su,  2004).     microcephalin  and ASPM  both have high rates of adaptive amino acid changes from early primates to humans.   It has  been  hypothesized  that  these  genes  are  involved  in  brain  size  determination because  severe  truncation  mutations  in  either  of  these  genes  lead  to  brain  sizes 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similar  to  that of early hominids, and  they are expressed  in  the  forebrains of  fetal mice  during  a  period  of  extensive  neurogenesis.    Recently,  Cdk5rap2  and  cenpj, which  have  also  been  identified  as  MCPH  genes,  were  shown  to  be  similarly expressed  during  mouse  brain  development  (Woods  et  al.,  2005).    Thus,  it  is suggested  that  these  MCPH  proteins  regulate  neurogenic  mitoses  by  controlling microtubule nucleation.  
Early Drosophila embryogenesis 
  Drosophila  melanogaster  is  an  ideal  model  organism  for  studying  the  cell cycle  in a developmental context.   Mutations are easily obtained,  the effects of cell cycle mutations are easily observed using fluorescence microscopy, the genome has been sequenced, and there are many tools and techniques available to allow for the rapid  mapping  and  characterization  of  mutant  genes.    Early  Drosophila embryogenesis  consists  of  thirteen  nuclear  divisions  driven  by  stockpiles  of maternal mRNA and protein that occur  in a syncytial blastoderm.   The cycles vary from  the  canonical  G1‐S‐G2‐M  cycles  in  that  they  have  no  intervening  gaps  or cytokinesis; instead, they consist of rapidly oscillating cycles of DNA replication and mitosis (~10 minute cycles) (for review, see Edgar and Lehner, 1996; Lee and Orr‐Weaver, 2003).   These rapid S‐M cycles do not depend upon cell growth or zygotic transcription until the fourteenth cycle, at which point cellularization occurs and a G2 phase  is  introduced (the mid‐blastula transition).   Cell cycle mutations that are maternal  effect‐lethal  affect  the  embryos  of  homozygous  females,  causing  defects during the  first  thirteen divisions due to a  lack of essential cell cycle proteins  that 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must  be  provided maternally.    The  genetic  tractability  of  the  fly  as  well  as  these early developmental characteristics make it easy to identify genes that are essential for normal S‐M cell cycles.  
The Xenopus laevis model system 











  Drosophila melanogaster is an ideal model organism for study of the cell cycle during  development  (reviewed  by  Foe  et  al.,  1993;  Lee  and  Orr‐Weaver,  2003). Drosophila  achieves  rapid  embryogenesis  by  using  a  streamlined  cell  cycle  that  is not  dependent  on  transcription  or  growth.  The  first  13  embryonic  cell  cycles  are nearly  synchronous  nuclear  divisions without  cytokinesis  occurring  in  the  shared cytoplasm of the syncytial blastoderm. These cycles differ from canonical G1‐S‐G2‐M cycles  in  that  they  have  no  intervening  gaps;  instead DNA  replication  and mitosis rapidly oscillate. Maternal RNA and protein stockpiles drive these abbreviated `S‐M' cycles  ( 10  minutes  each).  In  mammalian  embryos,  rapid  peri‐gastrulation divisions  that  occur  later  in  development  share  many  features  and  have  been proposed to be related by evolutionary descent to early embryonic divisions of flies and  frogs  (O'Farrell  et  al.,  2004).  Thus,  advances  gained  from  studies  of  these streamlined  cycles  in  `simple’  model  organisms  likely  have  relevance  for understanding mammalian cell cycles. 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 In a genetic screen for regulators of embryonic S‐M cycles, we identified the 
Drosophila homolog of a human disease gene, MCPH1  (microcephalin). Mutation of human MCPH1 causes autosomal recessive primary microcephaly, a developmental disorder  characterized  by  severe  reduction  of  cerebral  cortex  size  (Jackson  et  al., 2002).  Mcph1  is  highly  expressed  in  the  developing  forebrain  of  fetal  mice, consistent with its proposed role in regulating the number neuronal precursor cell divisions and, ultimately, brain size (Jackson et al., 2002). Human MCPH1 protein is predicted to contain three BRCA1 C‐terminal (BRCT) domains (reviewed by Glover et  al.,  2004;  Huyton  et  al.,  2000),  which  mediate  phosphorylation‐dependent protein‐protein interactions in cell‐cycle checkpoint and DNA repair functions.    Several  studies  have  implicated  human MCPH1  in  the  cellular  response  to DNA  damage.  The  DNA  checkpoint  is  engaged  at  critical  cell‐cycle  transitions  in response  to DNA damage or  incomplete  replication and  serves as  a mechanism  to preserve  genomic  integrity  (reviewed  by  Nyberg  et  al.,  2002).  Triggering  of  this checkpoint causes cell‐cycle delay, presumably to allow time for correction of DNA defects. When a cell senses DNA damage or incomplete replication, a kinase cascade is activated. Activated ATM and ATR kinases phosphorylate their targets,  including the checkpoint kinase Chk1, which is activated to phosphorylate its targets. The first clue  that  MCPH1  plays  a  role  in  the  DNA  damage  response  came  from  siRNA‐mediated  knockdown  studies  in  cultured  mammalian  cells  demonstrating  a requirement  for MCPH1  in  the  intra‐S phase and G2‐M checkpoints  in response  to ionizing radiation (Lin et al., 2005; Xu et al., 2004). Two recent reports have further implicated MCPH1  in  the DNA checkpoint, although puzzling discrepancies  remain 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to  be  resolved  (reviewed  by  Bartek,  2006).  One  report  indicates  that  MCPH1 functions  far  downstream  in  the  pathway,  at  a  level  between  Chk1  and  one  of  its targets, Cdc25 (Alderton et al., 2006). Another report (Rai et al., 2006) suggests that MCPH1  is  a  proximal  component  of  the  DNA  damage  response  required  for radiation‐induced foci formation (i.e. recruitment of checkpoint and repair proteins to damaged chromatin).    Additional functions have been reported for MCPH1. MCPH1– lymphocytes of microcephalic  patients  exhibit  premature  chromosome  condensation  (PCC) characterized  by  an  abnormally  high  percentage  of  cells  in  a  prophase‐like  state, suggesting  that  MCPH1  regulates  chromosome  condensation  and/or  cell‐cycle timing (Trimborn et al., 2004). A possible explanation for the PCC phenotype is that 
MCPH1‐deficient cells have high Cdk1‐cyclin B activity, which drives mitotic entry; decreased  inhibitory  phosphorylation  of  Cdk1  was  found  to  be  responsible  for elevated Cdk1 activity in MCPH1‐deficient cells (Alderton et al., 2006). It is not clear whether MCPH1's role in regulating mitotic entry in unperturbed cells is related to its  checkpoint  function;  intriguingly,  Chk1  has  similarly  been  reported  to  regulate timing of mitosis during normal division (Kramer et al., 2004). MCPH1  (also called 
Brit1)  was  independently  identified  in  a  screen  for  negative  regulators  of telomerase, suggesting that it may function as a tumor suppressor (Lin and Elledge, 2003). Further evidence for such a role comes from a study showing that gene copy number and expression of MCPH1  is reduced in human breast cancer cell lines and epithelial tumors (Rai et al., 2006). 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 We  report  here  the  identification  and  phenotypic  characterization  of 
Drosophila  mutants  null  for mcph1. We  show  that  syncytial  embryos  from mcph1 females exhibit genomic instability and undergo mitotic arrest due to activation of a DNA checkpoint kinase, Chk2. We find that, in contrast to reports of MCPH1 function in  human  cells,  the  ATR/Chk1‐mediated  DNA  checkpoint  is  intact  in  Drosophila 
mcph1 mutants. We propose that Drosophila MCPH1,  like its human counterpart, is required  for  proper  coordination  of  cell‐cycle  events;  in  early  embryos  lacking 




Drosophila stocks   Flies were maintained at 25°C using standard techniques (Greenspan, 2004). Wild‐type stocks used were y w or Oregon­R. Zuker alleles of mcph1 are cn bw and balanced over CyO. Zuker stock designations have been shortened and superscripted to  indicate  that  they  are  alleles  of  mcph1  (e.g.  ZII­1861  becomes  mcph1Z1861). Deficiency  strains,  P‐element  lines  for  mapping,  mutants  for  complementation testing  (grp1,  aurora1, wee1ES1),  nanos­Gal4:VP16  stock,  and mei­41  mutants  were from  Bloomington  Stock  Center.  mcph1  P‐element  insertions  were  from Bloomington  Stock  Center  (EY11307),  Kyoto  Stock  Center  (NP6229­5­1),  or  a  gift from  Steven  Hou  (l(2)SH0220).  tefu356, mnk6006  and  grp209  stocks  were  gifts  from Mike Brodsky, Bill Theurkauf and Tin Tin Su, respectively. 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Identification of new alleles of cell­cycle regulators   A  combination  of  female  meiotic  recombination,  deficiency  mapping  and direct complementation testing of candidates was used to identify mutants from our screen.  Complementation  testing with  known  cell‐cycle  regulators was  performed by assessing fertility of  females carrying a Zuker chromosome in trans to a known mutation. We used the following alleles: wee1ES1 (Price et al., 2000), grp1 (Fogarty et al., 1997), tefuΔ356 (Oikemus et al., 2004) and aur1 (Glover et al., 1995).   
Quantification of embryonic hatch rates   For hatch  rate  assays,  embryos  (0‐4 hours) were  collected on  grape plates, counted  and  aged  40  hours  at  25°C.  The  number  of  hatched  embryos  was determined by subtracting the number of unhatched (intact) embryos from the total number collected. Hatch rate is the ratio of hatched to total embryos expressed as a percentage.   
Genetic and molecular mapping of awol   The awol gene was localized by a combination of mapping strategies. We first screened  a  collection  of  deficiencies  on  the  second  chromosome  for  non‐complementation of the female sterility of awolZ1861. We found that females carrying 
awolZ1861  in  trans  to  Df(2R)BSC39  produced  embryos  with  the  awol  phenotype; similar results were obtained for awolZ0978 and awolZ4050. Thus, awol lies between the breakpoints of Df(2R)BSC39 in the polytene interval 48C5‐E1, a region that contains 35 genes. We mapped awol by P‐element‐induced male recombination (Chen et al., 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1998)  relative  to  the  following  insertion  lines: Mtork03905,  ERp60BG01854,  KG04952, 
otkEP2017  and  CG8378EP2501.  We  thereby  narrowed  awol  to  a  region  of  five  genes (including mcph1) that lie distal to ERp60BG01854 and proximal to KG04952. The awol stock used (cn ZII­1861 bw/CyO) has visible flanking markers cn and bw. The source of  transposase was Delta2­3  Sb.  Multiple  independent  recombinant  chromosomes were  recovered  for  each  P‐element  line  tested.  Genomic DNA was  extracted  from whole  flies  homozygous  for  awol  mutations  essentially  as  previously  described (Ballinger  and  Benzer,  1989).  mcph1  coding  regions  were  PCR‐amplified  from genomic DNA and sequenced.  
 
Generation of mcph1 excision line   P‐element insertions have been identified in the 5'‐UTR of mcph1 (NP6229­5­
1)  and within  its  largest  intron  (l(2)k06612,  l(2)SH0220  and EY11307)  (Grumbling and  Strelets,  2006).  l(2)k06612  is  no  longer  available  from  stock  centers.  We mapped  the  lethality  of  line  l(2)SH0220  (Oh  et  al.,  2003)  outside  of  the  mcph1 genomic  region  (data  not  shown).  We  found  that  EY11307  homozygous  and 
EY11307/mcph1Z1861  transheterozygous  females  are  viable,  fertile  and  produce embryos  with  nearly  wild‐type  levels  of  MCPH1  protein,  indicating  that  this  P‐insertion has  little effect on mcph1  transcription; similar results were obtained for 
NP6229­5­1 (data not shown). EY11307 is inserted in the 5'‐UTR of CG13189, which encodes  a  putative metal  ion  transporter,  and  the  largest  intron of mcph1  (Figure 2.2A).  All  EMS‐induced  mcph1  mutations  described  here  lie  outside  of  CG13189 (including  two  beyond  its  3'  end),  thereby  making  it  unlikely  that  decreased 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CG13189  activity  causes  the  awol  phenotype. We  performed  imprecise  P‐element excision of EY11307 to generate mcph1Exc21, which lacks two internal exons and part of the 3'‐most exon of mcph1; this excision left the 5'‐UTR, coding region and 3'‐UTR of CG13189 intact, but probably removed some of its promoter (Figure 2.2A).  
 
Embryo fixation, staining and microscopy   Embryos (1‐2 hours unless otherwise  indicated) were collected  for staining using standard techniques (Rothwell and Sullivan, 2000). For mouse anti‐α‐tubulin (DM1α,  1:500,  Sigma)  or  rabbit  anti‐Centrosomin  (1:10,000,  a  gift  from  W. Theurkauf)  staining,  embryos  were  dechorionated  in  50%  bleach,  fixed,  and devitellinized by shaking  in a mixture of methanol and heptane  (1:1). For staining with guinea pig anti‐MCPH1 (1:200) or mouse anti‐actin (1:400, MP Biomedicals) or co‐staining with anti‐α‐tubulin (YL1/2, Serotec, 1:250) and anti‐γ‐tubulin (GTU‐88, 1:250,  Sigma),  embryos  were  fixed  fore  20  minutes  in  a  mixture  of  3.7% formaldehyde in PBS and heptane (1:1). The aqueous layer containing formaldehyde was  removed  and  embryos  devitellinized  as  described  above.  Embryos  were incubated  in  primary  antibodies  at  4°C  overnight  except  for  anti‐MCPH1  (4°C  for three  days).  Secondary  antibodies  were  conjugated  to  Cy2  (Jackson ImmunoResearch).  Embryos  were  stained  with  propidium  iodide  (Sigma)  and cleared  as  previously  described  (Fenger  et  al.,  2000).  A  Nikon  Eclipse  80i microscope  equipped  with  a  CoolSNAP  ES  camera  (Photometrics)  and  Plan‐Apo (20x, 100x) or Plan‐Fluor 40x objectives was used;  for confocal  images, we used a Zeiss LSM510 microscope equipped with a Plan‐Neofluar 100x objective. 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Embryo squashes and quantification of DNA bridging   Methanol‐fixed embryos (40‐80 minutes) were placed  in 2‐µl drops of 45% acetic  acid  on  coverslips  for  1‐2  minutes.  Slides  were  lowered  onto  coverslips, inverted  and  embryos  squashed  by  hand  between  blotting  paper.  Samples  were snap‐frozen in  liquid nitrogen, coverslips removed, and slides immersed in ethanol at  –20°C  for  10  minutes  and  air‐dried.  Vectashield  mounting  medium  with  DAPI (Vector  Labs)  and  new  coverslips were  added  to  slides.  Fluorescence microscopy (100x  objective) was  used  to  visualize  DNA.  Late  anaphase  and  telophase  figures (cycle‐5  to  ‐7  embryos)  were  examined.  The  presence  of  one  or  more  linkages between DNA masses segregating to opposite poles was scored as a bridging defect.  
 
Live embryo imaging   For analysis of cell‐cycle timing, embryos (0‐1.5 hours) were dechorionated in  50%  bleach,  glued  (octane  extract  of  tape)  to  glass‐bottomed  culture  dishes (MatTek Corp.), and covered with halocarbon oil 27 (Sigma). DIC images of dividing embryos at 21.5‐22.5°C were captured (20‐second  intervals) using a Nikon Eclipse TE2000‐E  inverted microscope  with  a  CoolSNAP  HQ  CCD  camera  (Photometrics), Plan‐Apo  20x  objective,  and  IPLab  image  acquisition  software  (BD  Biosciences). Interphase  length  was  determined  by  counting  frame  numbers  from  nuclear envelope formation to breakdown. Mitosis length was determined by counting frame numbers  from  nuclear  envelope  breakdown  to  reformation.  Cycle  number  was determined by nuclear size and density. 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mcph1 cDNA clones and transgenes   cDNA  clones  encoding  MCPH1‐B  (LD43341)  or  MCPH1‐A  (LP15451)  were from  the  Drosophila  Gene  Collection  or  Drosophila  Genomics  Resource  Center, respectively. MCPH1‐B coding region was PCR‐amplified from LD43341, subcloned into  UASp  (Rorth,  1998),  and  transformed  into  y  w  flies  (Spradling,  1986).  To generate  IVT  constructs,  MCPH1‐B  coding  region  was  subcloned  into  pCS2.  The BRCT  domains  of  MCPH1  were  identified  using  ScanProsite.  Descriptions  of FlyBase's  annotation of mcph1 were based on version FB2006_01  (Grumbling and Strelets,  2006).  GenBank  accession  number  for  LP15451  encoding  MCPH1‐A  is EF587234.  
 
Polyclonal antibodies against MCPH1   Maltose‐binding protein  (MBP)  fused  to MCPH1‐B protein  (residues 1‐352) was used to produce antibodies. N‐terminal MCPH1‐B sequence was PCR‐amplified from LD43341 and subcloned into pMAL (New England Biolabs). MBP‐N‐MCPH1‐B was made in bacterial cells, purified using amylose beads, and injected into guinea pigs  for  antibody  production  (Covance).  Anti‐MCPH1  antibodies  were  affinity purified using standard techniques.  
 
Protein extracts and immunoblots   Protein extracts were made by homogenizing either embryos (1‐2 hours old unless otherwise indicated) or dissected tissues in urea sample buffer as described previously  (Moore  et  al.,  1998).  Proteins  were  transferred  to  nitrocellulose  for 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immunoblotting  using  standard  techniques. MCPH1‐A  and  ‐B  (unlabeled proteins) were  made  by  coupled  transcription‐translation  of  LP15451  and  LD43341, respectively, according to the manufacturer's protocol (Promega). Antibodies were used  as  follows:  guinea  pig  anti‐MCPH1  (1:200‐500),  mouse  anti‐Cyclin  B  (F2F4, 1:200,  Developmental  Studies  Hybridoma  Bank),  rabbit  anti‐pY15‐Cdk1  (1:1000, Upstate), rabbit anti‐Grapes (1:500, a gift from T. T. Su) (Purdy et al., 2005), mouse anti‐α‐tubulin  (DM1α,  1:5000,  Sigma), mouse  anti‐GAPDH  (1:1000,  Abcam).  HRP‐conjugated  secondary  antibodies  and  chemiluminescence  were  used  to  detect primary antibodies.  
 
DNA damage response assays   We used  a Mark  I  cesium‐137  irradiator  as  a  source  of  irradiation  (IR).  To test the G2‐M checkpoint post‐IR, we used the method of Brodsky et al. (Brodsky et al., 2000) except that fluorescently coupled secondary antibodies were used. To test the intra‐S phase checkpoint post‐IR, we used the method of Jaklevic and Su (Jaklevic and  Su,  2004)  except  that  larvae  were  exposed  to  40  Gray  (4000  Rad).  To  test sensitivity to  irradiation,  third  instar  larvae were untreated or exposed to 10 Gray (1000 Rad), transferred to food, and allowed to pupate and eclose as adults. Mutant chromosomes  were  balanced  over  CyO,  arm­GFP  (Sullivan  et  al.,  2000)  and homozygotes identified by lack of GFP signal. Numbers of pupae formed and empty pupal cases (due to eclosion) were scored up to 10 days post‐IR. Percentage eclosion (measure of survival) is the number of empty pupal cases expressed as a percentage of  total  pupae.  All  irradiated  larvae  formed  pupae  in  these  experiments.  To  test 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hydroxyurea  (HU)  sensitivity,  heterozygous  adults  (ten  males  and  ten  virgin females)  were  added  to  vials.  After  embryo  collection  (48  hours),  adults  were removed and 500 ml of 20 µM HU in water was added to food 24 hours later. Adult progeny were scored after 2 weeks. HU sensitivity is indicated by preferential loss of a specific genotypic class.  
 




Screen for Drosophila cell­cycle mutants identifies absent without leave (awol)   In an effort to identify genes required for S‐M cycles of the early embryo, we previously screened (Lee et al., 2003) a maternal‐effect lethal subset of a collection of  ethylmethanesulfonate  (EMS)‐mutagenized  lines  from  Charles  Zuker's  lab (Koundakjian  et  al.,  2004). We  screened  2400  lines  by  examining  DAPI‐stained embryos of homozygous females. Because early embryonic development is entirely regulated by maternally deposited mRNA and protein, only the maternal genotype is relevant  in  this  screen.  We  identified  33  lines  (12  chromosome  II  and  21 chromosome  III  mutants)  representing  26  complementation  groups  in  which  the majority of embryos from mutant females arrest at the syncytial blastoderm stage. 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We previously  identified  two alleles of giant nuclei, which prevents excessive DNA replication  in  S‐M  cycles  (Freeman  et  al.,  1986;  Renault  et  al.,  2003),  from  this collection  (Lee  et  al.,  2003).  We  have  now  identified  alleles  of  four  well‐known regulators of the cell cycle from the same screen (Table 2.1). All four genes encode protein kinases with conserved roles in cell‐cycle regulation. wee1, grapes, telomere 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Figure  2.1.  The  awol  phenotype.  Representative  syncytial  embryos  (A,B)  and mitotic spindles (C‐K) in embryos from wild‐type or awolZ1861/awolZ0978 females. (A,B)  DNA  staining  of  embryos  from  awol  females  shows  arrest  with  condensed chromosomes  and  unevenly  spaced  nuclei  (B)  compared  to  wild  type  (A).  (C‐G) Microtubules are in green and DNA in red. (C) Asynchronous neighboring nuclei in embryo  from awol  female  (left,  interphase;  right, mitosis).  (D) Metaphase  spindle with  duplicated  centrosomes  in  embryo  from  awol  female  shows  asynchronous nuclear  and  centrosome  cycles  (duplication  normally  occurs  in  telophase).  (E) Shortened,  barrel‐shaped  spindle  in  embryo  from awol  female.  (F) DNA displaced from metaphase plate  is  tethered by microtubules  to spindle pole  in embryo  from 















Genotype  MIa  Decreasedc  Increasedd    Barrel  Interactinge  Multipolar Wild type  54.1  0.2  0.0    0.1  0.0  0.0 
mcph1f  88.8  43.6  46.0    97.5  0.0  0.2 
mnk  54.2  0.2  0.1    0.0  0.2  0.0 
mnk 
mcph1Z1861 
57.5  0.2  1.2    0.0  15.0  6.0  
 
aMitotic index=% embryos in mitosis/total number of embryos (>100 embryos scored per 
genotype). The presence of both condensed chromosomes and a mitotic spindle was used 
as the criterion for scoring mitotic embryos 
bTo quantify spindle defects, >500 spindles from 25 embryos were scored per genotype 
cSpindles with centrosomal detachment at one or both poles 
dSpindles with >1 centrosome per pole (one or both poles) or ectopic centrosomes within 
spindle. Telophase spindles were not scored because centrosome duplication normally 
occurs at this phase in the early embryo 





occasionally  displaced  from  the  metaphase  plate  (Figure  2.1F).  Staining  for Centrosomin, a core centrosomal component (Li and Kaufman, 1996), revealed that lack  of  tubulin  foci  at  one  or  both  poles  in mutant‐derived  embryos  is  due  to  an absence  of  centrosomes  (Figure  2.1H,I;  Table  2.2);  we  occasionally  see  ectopic centrosomes  embedded  in  spindles  (Figure  2.1J;  Table  2.2).  On  the  basis  of  the phenotype  of  acentrosomal  mitotic  spindles,  we  have  given  the  name  `absent 
without leave' (`awol') to mutants of this complementation group. 
 
awol encodes the Drosophila homolog of MCPH1   We  localized  awol  to  a  region  including  five  genes  by  a  combination  of mapping  strategies  (see  Materials  and  Methods  for  details).  A  candidate  in  this region was the Drosophila homolog of the human disease gene, MCPH1  (Jackson et al.,  2002).  Sequencing  of  PCR‐amplified  mcph1  coding  region  from  homozygous mutant  genomic  DNA  revealed  that  awolZ0978  and  awolZ4050  are  distinct  missense mutations in mcph1 causing non‐conservative amino acid changes and awolZ1861 is a nonsense mutation resulting in severe truncation of the protein (Figure 2.2A). Thus, all  three  EMS‐induced  awol  alleles  represent  mutations  affecting  MCPH1  protein. Furthermore, females carrying any of these awol alleles in trans to a deletion of the 




Figure  2.2. mcph1  is  the  awol  gene.  (A)  The Drosophila  mcph1  gene  structure. Exons are represented by filled boxes, 5_‐ and 3_‐ UTRs by open boxes, and splicing events  by  thin  lines.  The  gene  CG13189  lies  within  the  largest  intron  of mcph1. Alternative  splicing  produces  transcript mcph1­RA  or  ‐RB.  Arrows  below  gene  or transcript names indicate direction of transcription. Positions of the point mutations in each of  the three EMS‐induced alleles of awol and resulting amino acid changes (numbers  refer  to  MCPH1‐B)  are  indicated  above  the  mcph1  gene.  Imprecise excision  of  P‐element  EY11307  (inverted  triangle)  generated  allele  mcph1Exc21 (deleted region indicated by gap). (B) Western analysis reveals trace amounts of or no MCPH1 protein in extracts of awol embryos relative to wild type (loading control: anti‐_‐tubulin).  The  excision  allele  (Exc21)  of  mcph1  serves  as  negative  control. 
Df=Df(2R)BSC39, which  removes  the mcph1 genomic  locus.  (C)  Comparison  of  the BRCT  domain  content  (hatched  boxes)  of  the  two  Drosophila  MCPH1  isoforms (MCPH1‐A and ‐B) and human MCPH1 protein (bottom). Positions of the amino acid changes in each of the three EMS‐induced alleles of awol are indicated by asterisks. A  double‐sided  arrow  indicates  the  region  of  MCPH1‐B  used  for  antibody production. 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mcph1Exc21 homozygous females produce embryos with the awol phenotype; similar results were obtained for females carrying this excision in trans to any of the EMS‐induced  awol  alleles  or  a  deletion  of  the mcph1  genomic  locus  (data  not  shown), further confirming that mutation of mcph1 causes the awol phenotype. Importantly, expression  of  transgenic mcph1  using  the UAS‐Gal4  system  (Brand  and  Perrimon, 1993;  Rorth,  1998)  restored  fertility  to  awolZ0978/awolZ4050  females,  resulting  in  a hatch rate of  40% of their embryos (Table 2.3). Thus, mcph1 is the awol gene. We used the MCPH1 isoform that  is most abundant  in the early embryo for transgenic rescue; it is possible that full rescue of the maternal‐effect lethality of awol mutants might additionally  require expression of  the  less abundant  isoform (see below  for description of MCPH1 isoforms; Figure 2.2A and Figure 2.3B).    To  further  characterize  our  mcph1  alleles,  we  generated  polyclonal antibodies against an MBP‐MCPH1 fusion. Anti‐MCPH1 antibodies recognize a major band  of  90  kDa,  consistent  with  the  predicted  size  of  MCPH1‐B,  when  used  to probe  immunoblots of wild‐type embryo extracts  (Figure 2.2B).  In contrast,  for all 
mcph1  alleles  identified  here,  we  detect  greatly  reduced  or  no MCPH1  protein  in mutant‐derived  embryos.  Thus,  all  of  these  alleles  are  null  (or  nearly  null)  for MCPH1 protein.  
MCPH1 isoforms differ in expression pattern and BRCT domain content   Our genetic data revealed that mcph1 null alleles are homozygous viable and that mcph1  is  required maternally  for  early  embryonic  development.  To measure MCPH1 levels throughout Drosophila development, we probed immunoblots of 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Figure  2.3.  Developmental  expression  of  alternate  MCPH1  isoforms.  (A,B) MCPH1  immunoblots.  (A)  Developmental  western  of  wild‐type  extracts  shows MCPH1  protein  is  present  in  a  variety  of  tissues  and  at  several  life‐cycle  stages. Extracts of embryos and testes were relatively underloaded (loading control: anti‐α‐tubulin).  (B) Type A and B MCPH1  isoforms produced  in vitro co‐migrate on SDS‐PAGE  with  endogenous  MCPH1  isoforms  abundant  in  testes  and  ovaries, respectively. 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extracts  from  various  developmental  stages  with  anti‐MCPH1  antibodies  (Figure 2.3A). As expected, MCPH1 is abundant in ovaries and early embryos, whereas older embryos  under  zygotic  control  have  relatively  low  amounts. MCPH1  is  present  in larval brains and  imaginal discs but undetectable  in adult brain extracts. Although high levels of MCPH1 are present in adult testes, it is not required for male fertility (data not shown).    Two major  isoforms of MCPH1 were detected by  immunoblotting:  90 kDa (predominant in ovaries and embryos) and  110 kDa (predominant in testes). Both isoforms  were  detected  in  larval  tissues.  The  most  recent  mcph1  gene  model annotated by FlyBase predicts two splice variants (A and B) differing at their 5'‐ends that encode proteins with distinct amino termini (Grumbling and Strelets, 2006). We compared  sizes  of  recombinant  MCPH1‐A  and  ‐B  proteins  (produced  by  in  vitro transcription‐translation  reactions)  to  that  of  endogenous  MCPH1  isoforms  by immunoblotting. We found that the gel mobilities of MCPH1‐A and ‐B closely match that  of  MCPH1  in  testes  and  ovaries,  respectively;  thus,  MCPH1‐A  is  the  110  kDa isoform  that  is  abundant  in  testes,  and MCPH1‐B  is  the  90  kDa  isoform  that  is abundant in ovaries and early embryos (Figure 2.3B).    We observed a discrepancy between relative sizes of MCPH1‐A and ‐B on our immunoblots (A larger than B; Figure 2.3B) and as predicted by FlyBase [779 versus 826 amino acids,  respectively  (Grumbling and Strelets, 2006)]. We were unable  to find 3'‐end sequence data for mcph1­A on public databases, so we fully sequenced a representative clone (LP15451) and found it to encode a protein of 981 amino acids, which  closely  matches  our  estimated  size  of  110  kDa  for  endogenous  MCPH1‐A. 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Furthermore, our sequencing revealed that mcph1­A contains coding sequence from both mcph1 and CG30038, a gene predicted to overlap the 3'‐end of mcph1  (Figure 2.2A).  Thus,  mcph1­A  and  ­B  are  alternatively  spliced  at  both  ends,  producing proteins that differ  in their N‐ and C‐terminal regions (Figure 2.2C), and predicted gene CG30038 comprises alternatively spliced exons of mcph1­A.    MCPH1‐A  and  ‐B  proteins  both  contain  BRCT  domains  (three  or  one, respectively). The arrangement of BRCT domains within MCPH1‐A (one N‐terminal and  two  paired  C‐terminal)  resembles  that  of  human  MCPH1  (Figure  2.2C). 
Drosophila  and  human  MCPH1  have  highest  sequence  identity  in  their  BRCT domains  (37.6%,  52.5%  and  26.8%  between  the  N‐terminal,  first  C‐terminal,  and second C‐terminal domains, respectively). The presence of extended amino termini in both Drosophila isoforms relative to human MCPH1 raises the possibility that the reported human sequence (Jackson et al., 2002) may not be full‐length.   





Figure 2.4. MCPH1 is a nuclear protein. Wild‐type syncytial embryos were fixed and  stained  with  an  antibody  against  MCPH1  (green)  and  DNA  dye  (red). Representative embryos in various cell‐cycle stages are shown. MCPH1 localizes to the nucleus during interphase and prophase and is no longer detectable during later stages  of  mitosis  (following  nuclear  envelope  breakdown).  No  MCPH1  signal  is detected in interphase nuclei of mcph1Z1861 mutants (negative control). Bar, 10 μm. 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Human MCPH1 has been reported to localize to the nucleus (Lin et al., 2005) as well as  to  centrosomes  (Jeffers  et  al.,  2007;  Zhong  et  al.,  2006);  we  observe  no centrosomal localization for MCPH1 in syncytial embryos of Drosophila.  
 
Mitotic arrest in mcph1 syncytial embryos is a consequence of Chk2 activation  The  defective  mitotic  spindles  of  embryos  derived  from  mcph1  females (hereafter referred to as `mcph1 embryos') exhibit key features reminiscent of Chk2‐mediated  centrosomal  inactivation.  In  particular,  these  spindles  are  short,  barrel‐shaped, anastral, and associated with poorly aligned chromosomes (Figure 2.1). Late syncytial  embryos  of  Drosophila  use  a  two‐stage  response  to  DNA  damage  or replication defects (Sibon et al., 2000). The DNA checkpoint mediated by Meiotic 41 (MEI‐41)  and  Grapes  (GRP),  the Drosophila  orthologs  of  ATR  (ATM‐Rad3‐related) and Chk1 kinases, respectively, delays mitotic entry via inhibitory phosphorylation of  Cdk1  to  allow  repair  of DNA damage  or  completion  of  replication  (Sibon  et  al., 1999;  Sibon  et  al.,  1997). When  this  checkpoint  fails,  a  secondary  damage‐control system operating in mitosis is activated; resulting changes in spindle structure block chromosome segregation, presumably to stop propagation of defective DNA (Sibon et  al.,  2000;  Takada  et  al.,  2003).  This  damage‐control  system,  known  as centrosomal inactivation, is mediated by the checkpoint kinase Chk2 (Takada et al., 2003).    Loss  of  γ‐tubulin  from  centrosomes  of  mitotic  spindles  is  another characteristic  feature  of  Chk2‐mediated  centrosomal  inactivation.  We  detected decreased  γ‐tubulin  staining  of  centrosomes  during  mitosis  in  mcph1  embryos 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compared  to wild  type  (Figure 2.5). We  typically observe complete detachment of centrosomes from spindles in mcph1 embryos. High levels of DNA damage induced by intense laser illumination can similarly cause complete centrosomal detachment from spindle poles of wild‐type embryos (Takada et al., 2003),  suggesting  that  the spindle  changes  we  observe  in  mcph1  embryos  represent  an  extreme  form  of centrosomal inactivation.    To  determine whether mitotic  defects  in mcph1  embryos  are  due  to  Chk2‐mediated centrosomal  inactivation, we created  lines doubly mutant  for mcph1 and 
maternal nuclear kinase (mnk), also known as  loki, which encodes Drosophila Chk2 (Abdu  et  al.,  2002;  Brodsky  et  al.,  2004; Masrouha  et  al.,  2003;  Xu  et  al.,  2001).  A similar  approach  has  been  used  to  demonstrate  Chk2‐mediated  centrosomal inactivation  in grp, mei­41  and wee1  embryos  (Stumpff  et  al.,  2004;  Takada  et  al., 2003).  Null mnk  mutants  are  viable  and  fertile,  but  they  are  highly  sensitive  to ionizing  radiation  (Xu  et  al.,  2001).  Remarkably,  we  found  that mnk  suppresses many  of  the mitotic  defects  of mcph1  embryos  (Figure  2.6A‐D;  Table  2.2). Mitotic spindles  are  restored  to  near‐normality:  in  contrast  to  the  short,  barrel‐shaped, anastral spindles of mcph1 embryos, mnk mcph1 embryos have elongated spindles with  attached  centrosomes.  Thus,  Chk2  activation  contributes  significantly  to  the 




Figure  2.5.  Decreased  γ­tubulin  staining  of  centrosomes  in mcph1  embryos. Syncytial embryos from wild‐type or mcph1Exc21  females were fixed and co‐stained with  antibodies  against  α‐tubulin  (red)  and  γ‐tubulin  (green).  Representative mitotic spindles are shown. Bar, 10 μm. 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Figure  2.6.  Suppression  of mcph1  by Chk2  (mnk).  (A‐J)  Representative mitotic spindles  in  syncytial  embryos  and  whole‐mount  embryos  from  mcph1Z1861,  mnk 
mcph1Z1861 and wild‐type females. Bars, 20 µm. (A‐F) Microtubules are in green and DNA  in  red;  low  (A,B)  and  high  (C‐F)  magnification  views. mcph1  embryos  have 
awol‐type  (barrel‐shaped,  acentrosomal)  spindles  (A,C).  awol  phenotype  is suppressed in mnk mcph1 embryos (B,D): note restoration of elongated spindles and attached centrosomes. Other defects are seen in mnk mcph1 embryos, such as DNA shared by two spindles (E) and DNA bridging (F, arrow). (G,H) Cellularized embryos (2‐3  hours)  stained  for  actin  (green)  and  DNA  (red). mnk  mcph1  embryos  reach gastrulation with irregular cell size and DNA content (G) compared to wild type (H). (I,J)  DNA‐stained  embryos  (3‐4  hours).  mnk  mcph1  embryos  (I)  arrest  peri‐gastrulation with aberrant morphology compared to wild type (J). (K) Quantification of suppression of developmental arrest of mcph1Z1861 embryos by mnk. 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developing near gastrulation. Thus, Chk2 activation causes mcph1 embryos to arrest at  the  syncytial  stage.  Cellularized mnk mcph1  embryos  show  irregularities  in  cell size  and  shape  and  intensity  of DNA  staining;  gastrulation  is  grossly  aberrant. We conclude that mutation of mnk removes the `brakes' from mcph1 embryos, allowing further  nuclear  divisions  and  development  in  the  face  of  DNA  defects,  which eventually become so severe that embryos die perigastrulation.   
mcph1  syncytial  embryos  exhibit  a  high  frequency  of  chromatin  bridging   We  sought  to understand  the primary defects  leading  to Chk2  activation  in 
mcph1  embryos.  Known  triggers  of  Chk2‐mediated  centrosomal  inactivation  are mitotic  entry  with  incompletely  replicated  or  damaged  DNA  (Sibon  et  al.,  2000; Takada  et  al.,  2003).  Although mnk  suppresses  many  of  the  cell‐cycle  defects  of 
mcph1 embryos, we occasionally observe abnormal DNA aggregates shared by more than  one  spindle  and  multipolar  spindles  in mnk  mcph1  embryos  that  progress beyond the usual mcph1 arrest point (Figure 2.6E; Table 2.2). These defects are not observed in mnk embryos, suggesting that they are due to a lack of mcph1. In whole mounts of both mnk mcph1 and mcph1 embryos, we frequently observe chromatin bridging, which  represents  a  physical  linkage  of  chromosomes  that  prevents  their segregation  to  opposite  poles  at  anaphase  (Figure  2.6F;  data  not  shown);  this bridging  could  result  from  mitotic  entry  with  unreplicated,  damaged,  and/or improperly  condensed  chromosomes.  We  were  prohibited  from  quantifying  this phenotype, however, as yolk proteins obscure nuclei that lie deep within the interior of early syncytial embryos. We circumvented this problem by adapting a larval brain 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Figure  2.7.  Chromatin  bridging  in  mcph1  embryos.  Syncytial  embryos  were squashed  and  the  DNA  stained.  (A)  Representative  late  anaphase‐to‐telophase figures (images shown at same magnification). DNA bridging and increased pole‐to‐pole  distances  are  seen  in  squashes  of mcph1Z1861/mcph1Z0978  and mnk mcph1Z1861 embryos. Bars, 10 µm. (B) Quantification of DNA bridging in mcph1Z1861/mcph1Z0978 and  mnk  mcph1Z1861  embryo  squashes.  Wild‐type  and  mnk  embryos  served  as controls. 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mcph1 is not required for the DNA checkpoint in Drosophila   Chk2‐mediated  centrosomal  inactivation  can  be  triggered  in  Drosophila syncytial  embryos  by  DNA  damaging  agents,  the  DNA‐replication  inhibitor aphidicolin, or mutation of DNA checkpoint components (MEI‐41 or GRP) or WEE1, a kinase that prohibits mitotic entry via inhibitory phosphorylation of Cdk1 (Sibon et al., 2000; Stumpff et al., 2004; Takada et al., 2003). Human MCPH1‐deficient cells show defective G2‐M and intra‐S phase checkpoint responses following DNA damage (Alderton  et  al.,  2006;  Lin  et  al.,  2005;  Xu  et  al.,  2004).  In  light  of  these  studies linking  human MCPH1  to  the  ATR/Chk1  pathway  and  our  results  that Drosophila 
mcph1 embryos undergo Chk2‐mediated arrest, we sought to determine if MCPH1 is required for the DNA checkpoint in Drosophila.    Because  MEI‐41  and  GRP  are  required  during  larval  stages  for  the  DNA checkpoint (Brodsky et al., 2000; Jaklevic and Su, 2004), we tested whether MCPH1 is required. In response to ionizing radiation (IR), eye‐antennal imaginal disc cells of wild‐type  larvae  undergo  G2  arrest.  We  found  that mcph1  larvae  also  exhibit  IR‐induced  G2  arrest  under  conditions  in  which mei­41  larvae  fail  to  arrest  (Figure 2.8A). We next  tested  the  intra‐S phase response  to  IR  in  larval brain cells. mcph1 brains exhibited IR‐induced intra‐S phase arrest similar to that of wild type, whereas no  arrest  was  seen  in mei­41  brains  (Figure  2.8B).  We  also  tested  sensitivity  of 




to DNA­damaging  agents.  (A,B)  Cell‐cycle  checkpoints  in mcph1  larvae.  Bars,  50 µm.  (A)  G2‐M  checkpoint.  Eye‐antennal  imaginal  disks  were  dissected  from untreated  (left)  or  irradiated  (right)  larvae,  fixed,  and  stained  with  antibodies against  phosphorylated  Histone  H3  (anti‐PH3),  a  marker  of  mitotic  cells.  Lack  of anti‐PH3 staining post‐IR indicates G2 arrest. Representative disks are shown (with at  least  twelve  discs  scored  per  genotype).  (B)  Intra‐S  phase  checkpoint.  Brains were  dissected  from untreated  (left)  or  irradiated  (right)  larvae  and  labeled with BrdU.  Decreased  BrdU  staining  in  brain  lobes  (arrows)  post‐IR  indicates  intra‐S phase arrest. Representative brains are shown (with at  least six brains scored per genotype).  (C,D)  Survival  of mcph1  larvae  following  exposure  to  DNA‐damaging agents.  (C) Sensitivity  to hydroxyurea  (HU). Larvae were grown on  food minus or plus HU and allowed to develop. For each genotype, the ratio of homozygous mutant to total progeny is expressed as a percentage with total number of adult flies scored shown  in parentheses.  (D) Sensitivity  to  IR. Third  instar  larvae were untreated or exposed  to  low‐dose  irradiation  and  allowed  to  develop.  For  each  genotype,  the ratio of eclosed adults to total pupae is expressed as a percentage with total pupae shown in parentheses. 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mei­41,  survive normally  following  low‐dose  IR  exposure  (Figure 2.8D),  indicating that MCPH1 is not required for DNA repair (Jaklevic and Su, 2004).   The  MEI‐41/GRP‐mediated  DNA‐replication  checkpoint  is  also developmentally  activated  at  the midblastula  transition  (MBT)  (Sibon  et  al.,  1999; Sibon et al., 1997). Rapid S‐M cycles of the early embryo are under maternal genetic control, and the switch to zygotic control occurs at  the MBT after cycle 13. During late  syncytial  cycles  (11‐13),  titration  of  a  maternal  DNA‐replication  factor  is thought  to  induce a mei­41/grp‐dependent checkpoint  that  causes Cdk1  inhibitory phosphorylation.  Mitotic  entry  is  thereby  slowed,  presumably  to  allow  time  to complete  replication.  Embryos  from  mei­41  or  grp  females  fail  to  lengthen interphase in late syncytial cycles and undergo extra S‐M cycles (Sibon et al., 1999; Sibon et al., 1997).    We  asked  if  MCPH1  is  required  for  the  MEI‐41/GRP‐dependent  DNA‐replication  checkpoint  at  the  MBT. mcph1  embryos  undergo  arrest  due  to  Chk2 activation  prior  to  their  reaching  cortical  divisions  (cycles  10‐13).  Thus,  to  test whether  mcph1  is  required  for  cell‐cycle  delay  at  the  MBT,  we  performed  live analysis  of  cortical  divisions  in mnk mcph1  embryos  that  lack  a  functional  Chk2‐mediated checkpoint. We reasoned that any primary defects in cell‐cycle timing due to  mutation  of  mcph1  would  still  be  apparent  in  mnk  mcph1  embryos.  This assumption  is strengthened by a recent study showing  that mnk grp  embryos  that progress through the MBT due to lack of Chk2‐mediated arrest retain the cell‐cycle timing defects of grp embryos (Takada et al., 2007). We monitored timing of nuclear envelope  breakdown  and  reformation  by  differential  interference  contrast 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microscopy  (DIC)  and  found  no  significant  differences  in  interphase  or  mitosis lengths in mnk mcph1 and wild‐type embryos (Figure 2.9A).   To  further  confirm  that  the  DNA‐replication  checkpoint  is  intact  in  mnk 
mcph1 embryos, we assessed the extent of  inhibitory phosphorylation of Cdk1 and found it to be comparable to that of wild type (Figure 2.9B). We also found wild‐type levels of Cyclin B and Cyclin A in mnk mcph1 embryos (Figure 2.9C; data not shown). Low levels of Chk1 protein have been reported in MCPH1 siRNA human cells (Lin et al., 2005; Xu et al., 2004), but we detected normal levels of Grapes (Chk1) in mcph1 and mnk mcph1  embryos  (Figure  2.9D).  Thus,  our  data  do  not  support  a  role  for 
Drosophila MCPH1 in control of cell‐cycle timing in syncytial embryos via regulation of Cdk1 phosphorylation, Cyclin B, or Grapes levels. 
 
mcph1 cooperates with mei­41 and grp to regulate syncytial divisions   Previous  studies  of  grp  and  mei­41  embryos  largely  focused  on  mitotic defects in cortical nuclear divisions, which are amenable to live analysis (Sibon et al., 2000;  Takada  et  al.,  2003).  Given  the  earlier  arrest  point  of mcph1  embryos,  we initially  concluded  that  mcph1  and  mei­41/grp  must  have  discrete  roles.  We subsequently  found,  however,  that  a  sizeable  fraction  of  embryos  (17‐33%)  from homozygous  or  hemizygous  grp  females  arrest  in  pre‐cortical  cycles  (1‐9)  with acentrosomal,  barrel‐shaped  spindles  nearly  identical  to  that  of  mcph1  (Figure 2.10A). We  obtained  similar  results  for  all  three grp  alleles  tested  (Figure  2.10B), including the null grp209  (Larocque et al., 2007). Our data and a previous report of defective Cyclin A proteolysis in pre‐cortical grp embryos (Su et al., 1999) have 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Figure  2.9.  Intact  DNA­replication  checkpoint  and  normal  Cyclin  B  levels  in 




Figure 2.10. mcph1  cooperates with mei­41  and grp  in  the early embryo.  (A) Mitotic  spindle  from  a  pre‐cortically  arrested grapesZ5170  embryo  resembles awol‐type spindles of mcph1  embryos. Microtubules are  in green and DNA  in  red. Scale bar: 10 µm. (B) Quantification of mcph1‐like arrest in grp embryos (2‐4 hours). (C) 
mcph1 dominantly enhances mei­41 embryonic lethality. Introduction of one copy of 
mcph1Z1861  into  a  semi‐sterile  mei­41  background  (mei­41RT1/mei­41D5)  reduces embryonic  hatch  rate more  than  threefold.  (D)  Immunoblotting  shows  slower  gel mobility of MCPH1 in mei­41RT1 or grp1 embryos (1‐2 hours) relative to wild type.  
  54 
established a role for grp in regulating the cell cycles of early syncytial embryos. We also  found that mcph1 dominantly enhances a weak mei­41 phenotype  to a degree similar  to  that  of  grp  (Figure  2.10C).  Intriguingly,  by  immunoblotting,  we consistently observe an upward mobility shift in MCPH1 in grp or mei­41 embryonic extracts (Figure 2.10D). Taken together, these data suggest that MCPH1 cooperates with MEI‐41 and GRP to regulate the cell cycles of the early embryo via a mechanism independent of Cdk1 phosphorylation.  
mcph1 males exhibit defects in adult brain structure   On the basis of the reduced brain size of patients with mutation of mcph1, we tested whether mutation of Drosophila mcph1 affects brain development. We did not observe an obvious change in overall brain size, but we did observe morphological defects  in  central  brain  structures. The mushroom bodies  (MBs) of  the Drosophila adult  brain  are  bilaterally  symmetrical  structures  required  for  olfactory  memory and  other  complex  adaptive  behaviors  (de  Belle  and  Heisenberg,  1994).  MB structure  is  stereotyped,  and  gross  morphological  brain  defects  often  uncover structural defects in MBs. The 2500 intrinsic neurons in each MB can be subdivided into  at  least  three  morphologically  well‐defined  subsets  (αβ, α’β’,  or  γ)  based  on bundling  of  their  axonal  projections  in  the  region  of  the  MBs  called  the  lobes (Crittenden  et  al.,  1998).  Each  MB  neuron  contributing  to  the  αβ  subdivision bifurcates and sends one axon branch vertically to the αlobe and one horizontally to the β‐lobe. Anti‐Fasciclin II (FasII) antibodies strongly  label MB neurons that  lie  in the  αβ‐lobes  (Grenningloh  et  al.,  1991),  thereby  allowing  straightforward 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visualization of developmental defects. 
 Our  initial  analysis  revealed obvious morphological MB defects  in brains of 





Figure 2.11. Defects in male mcph1 brains. Adult male brains were stained with anti‐FasII  antibodies  to  visualize mushroom  body  (MB) αβlobes  and  the  ellipsoid body of the central complex (CC). (A) MB αβlobes of wild‐type brains are symmetric, whereas MBs of mcph1 brains are occasionally defective with missing or diminished 
αβlobes  (arrowheads). Df=Df(2R)BSC39, which  removes  the mcph1  genomic  locus. (B)  Quantification  of  brain  defects  in  mcph1  males.  Sample  number  for  each genotype is indicated in parentheses (top). 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DISCUSSION  
 We  identified  Drosophila  mcph1,  the  homolog  of  the  human  primary microcephaly  gene MCPH1,  in  a  genetic  screen  for  cell‐cycle  regulators  and  have shown that it is required for genomic stability in the early embryo. Three additional primary  microcephaly  (MCPH)  genes  have  been  identified  in  humans:  ASPM, 
CDK5RAP2, and CENPJ (reviewed by Cox et al., 2006). Much of our understanding of the  biological  functions  of  the  proteins  encoded  by  human MCPH  genes  has  come from  studies  of  their Drosophila  counterparts. Mutation of abnormal  spindle  (asp), the Drosophila  ortholog  of ASPM,  results  in  cytokinesis  defects  and  spindles  with poorly  focused  poles  (do  Carmo Avides  and Glover,  1999; Wakefield  et  al.,  2001). The  Drosophila  ortholog  of  CDK5RAP2,  centrosomin  (cnn),  is  required  for  proper localization of other centrosomal components (Li and Kaufman, 1996; Megraw et al., 1999). Sas­4, the Drosophila ortholog of CENPJ, is essential for centriole production, and the mitotic spindle is often misaligned in asymmetrically dividing neuroblasts of 
Sas­4  larvae (Basto et al., 2006). Whereas all of  these primary microcephaly genes are  critical  regulators  of  spindle  and  centrosome  functions,  mitotic  defects  in 
Drosophila mcph1 mutants are  largely secondary  to Chk2 activation  in response  to DNA  defects;  thus,  mcph1  probably  represents  a  distinct  class  of  primary microcephaly genes.  MCPH1  is a BRCT domain‐containing protein,  suggesting  that  it plays a  role  in  the DNA  damage  response.  Conflicting  models  of  MCPH1  function,  however,  have emerged from studies of human cells as it has been proposed to function at various 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levels in this pathway: upstream, at the level of damage‐induced foci formation (Rai et al., 2006) and further downstream, to augment phosphorylation of targets by the effector  Chk1  (Alderton  et  al.,  2006).  The  phenotype  of  embryos  from null mcph1 females is more severe than that of embryos from null grp females, suggesting that enhancement of phosphorylation of GRP (Chk1) substrates is not the sole function of MCPH1.  Furthermore,  we  found  both  the  DNA  checkpoint  in  larval  stages  and  its developmentally regulated use at the MBT to be intact in mcph1 mutants, suggesting a requisite role for MCPH1 in the DNA checkpoint evolved in higher organisms.  Studies  of  human  cells  suggest  a  role  for  MCPH1  in  regulation  of  chromosome condensation.  Microcephalic  patients  homozygous  for  a  severely  truncating mutation in MCPH1 show increased frequency of G2‐like cells displaying premature chromosome  condensation  (PCC) with  an  intact  nuclear  envelope  (Alderton  et  al., 2006; Trimborn et al., 2004). Depletion of Condensin II subunits by RNAi in MCPH1‐deficient cells leads to reduction in the frequency of PCC, suggesting that MCPH1 is a negative regulator of chromosome condensation (Trimborn et al., 2006). Alderton et al.  (Alderton  et  al.,  2006)  observed  a  decreased  level  of  inhibitory  phosphates  on Cdk1 that correlated with PCC in MCPH1‐deficient cells. The authors proposed that MCPH1 maintains  Cdk1  phosphorylation  in  an  ATR‐independent manner  because PCC  is  not  seen  in  cells  of  patients  with  Seckel  syndrome,  which  is  caused  by mutation of ATR; residual ATR present in these cells, however, may be sufficient to prevent PCC (O'Driscoll et al., 2003). Furthermore, in several experimental systems, ATR and Chk1 have been implicated in an S‐M checkpoint that prevents premature mitotic entry with unreplicated DNA (reviewed by Petermann and Caldecott, 2006). 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We have shown that embryos from grp (Chk1) females occasionally undergo mcph1‐like  arrest  in  early  syncytial  cycles,  prior  to  the  time  at  which  inhibitory phosphorylation  of  Cdk1  is  thought  to  control  mitotic  entry.  Thus,  decreased signaling  through  the  DNA  checkpoint  resulting  in  less  Cdk1  phosphorylation  is unlikely to explain this mcph1‐like arrest. In contrast to studies of MCPH1‐deficient human cells, we detect no decrease in pY15‐Cdk1 levels in mcph1 embryos allowed to progress beyond their normal arrest point by mutation of mnk (Chk2). Based on these  data  and  the  PCC  phenotype  associated with  loss  of MCPH1  in  humans,  we propose a model in which MEI‐41/GRP cooperate with MCPH1 in syncytial embryos in  a  Cdk1‐independent  manner  to  delay  chromosome  condensation  until  DNA replication  is  complete.  In  the  absence  of  mcph1,  we  hypothesize  that  embryos condense chromosomes before finishing S phase, resulting in DNA defects (bridging chromatin),  Chk2  activation,  and mitotic  arrest. We were  precluded  from  directly monitoring chromosome condensation in mnk mcph1 embryos expressing Histone‐GFP as previously described (e.g. Brodsky et al., 2000) because we were unable to establish fly stocks carrying this transgene in the mnk background. Live imaging of 
mcph1  embryos  was  not  technically  feasible  because  they  arrest  prior  to  cortical stages,  and  yolk  proteins  obscure  more  interior  nuclei  in  early  embryos.  grp embryos  have  been  reported  to  initiate  chromosome  condensation  with  normal kinetics  (Yu  et  al.,  2000),  although  a  subtle  PCC  phenotype  might  be  difficult  to detect. Support  for  our  model  that  MCPH1  allows  completion  of  S  phase  by  delaying chromosome  condensation  comes  from  the  observation  that  inhibition  of  DNA 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replication  in  syncytial  embryos  (via  injection  of  aphidicolin  or  HU)  results  in phenotypes  similar  to  those  observed  in  mcph1  embryos,  including  chromatin bridging, which is presumably a direct consequence of progressing through mitosis with  unreplicated  chromosomes  (Raff  and  Glover,  1988),  and  Chk2  activation (Takada  et  al.,  2003).  Alternatively, mcph1  might  be  required  during  S  phase  for timely  completion  of  DNA  synthesis;  in  this  case, mcph1  embryos  would  initiate chromosome  condensation  with  normal  kinetics  prior  to  completing  replication. Coordination of S‐phase completion and mitotic entry may be particularly critical in the rapid cell cycles of the early embryo that lack gap phases and may explain why loss of Drosophila mcph1 is most apparent at this developmental stage. Interestingly, even  in  the  absence  of  exogenous  genotoxic  stress, MCPH1‐deficient  human  cells also exhibit a high  frequency of chromosomal aberrations  (Rai et al., 2006), which may be a consequence of PCC.  An evolutionary role for mcph1 in expansion of brain size along primate lineages has emerged  in recent years (reviewed by Woods et al., 2005).  In brains of Drosophila 
mcph1  males,  we  find  low‐penetrance  defects  in  MB  structure.  Both  MCPH1 isoforms  are  expressed  in  larval  brains,  and  all mcph1  mutations  described  here affect  both  isoforms,  so  it  is  unclear whether MB  formation  requires  one  or  both isoforms. The lack of MB defects in mcph1 females is puzzling because both isoforms are  found  in  male  and  female  larval  brains  (data  not  shown);  other  sex‐specific factors  are  probably  involved.  Larval  brains  of  mcph1  males  show  no  obvious aneuploidy  (data  not  shown)  or  spindle  orientation  defects  (Andrew  Jackson, personal  communication),  so  the  cellular  basis  for  these  defects  remains  to  be 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 Regulated proteolysis  is  critical  for proper cell‐cycle  timing. The Anaphase‐Promoting  Complex  (APC)  is  a  multisubunit  E3  ligase  that  catalyzes  ubiquitin‐mediated  degradation  of  key  cell‐cycle  proteins,  thereby  coordinating  orderly progression  (reviewed  in  Harper  et  al.  2002;  Thornton  and  Toczyski  2006).  APC substrates  include  mitotic  cyclins  (King  et  al.  1995)  and  Securin,  an  inhibitor  of sister‐chromatid  separation  (Shirayama  et  al.  1999).  Cdc20  and  Cdh1,  which  are APC activators, play critical roles  in substrate specificity determination and timing of degradation.   The APC controls events  in mitosis and G1 and influences S‐phase events; thus, it affects many aspects of cell‐cycle progression.   In Vitro Expression Cloning (IVEC) screening approaches have been used to successfully identify candidate proteins involved in a variety of processes including kinase or protease substrates, and protein binding (reviewed in King et al. 1997).  In this  approach,  pools  of  radiolabeled  proteins  generated  from  cDNA  libraries  are incubated under  the  appropriate  biochemical  conditions  and  assayed  for  changes. 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Caveats  to  this  approach  include  clones  that  may  be  over‐  or  under‐represented within a particular library.  Also, inputs are initially unknown requiring progressive subdivision  of  pools  until  individual  clones  can  be  isolated.    A  modified  IVEC approach  in which  clones were obtained  from  the Drosophila Gene Collection has been successfully used to identify substrates of the Pan Gu kinase (Lee et al. 2005).  The  advantage  of  this  approach,  termed  “DIVEC”  (for  “Drosophila  IVEC”),  is  that each  clone  is  fully  sequenced,  singly  represented  within  the  collection,  and annotated, thus allowing one to easily identify positives within pools of radiolabeled proteins. 




Drosophila stocks   Flies were maintained at 25˚C using standard techniques (Greenspan 2004). Wild‐type  stocks  used  were  y  w.    nanos­Gal4:VP16  and  fizzy­related  stocks  were obtained from the Bloomington Stock Center.  morula mutant stocks were gifts from Terry Orr‐Weaver.    
Drosophila mcph1 cDNA clones and transgenes  cDNA clones encoding MCPH1‐B (LD43341) were from the Drosophila Gene Collection or Drosophila Genomics Resource Center.  The first putative Dbox (RXXL) was mutated to AXXL using the Stratagene QuikChange II kit. MCPH1‐B or MCPH1‐B‐Dbox coding region was PCR‐amplified and subcloned into a UASp (Rorth 1998) derivative encoding  six N‐terminal Myc  tags.   UASp‐Myc‐MCPH1­B  and UASp‐Myc‐
MCPH1­B­Dbox were  transformed  into y w  flies  as described  (Spradling 1986). To generate  IVT  constructs,  MCPH1‐B  coding  region  was  subcloned  into  pCS2  or derivatives encoding six N‐ or C‐terminal Myc tags. DeltaN‐MCPH1‐B (N‐terminal 40 amino acids deleted) and DeltaDbox‐MCPH1‐B (RRPLH at positions 36‐40 changed to alanines) were made by PCR‐based mutagenesis.   
Polyclonal antibodies against Drosophila MCPH1 
  MBP fused to MCPH1‐B (N‐terminal 352 amino acids) was used to produce antibodies.  N‐terminal MCPH1‐B  sequence was  PCR‐amplified  from  LD43341  and 
  65 
subcloned  into  pMAL  (New  England  Biolabs).  MBP‐N‐MCPH1‐B  was  made  in bacterial  cells,  purified  using  amylose  beads,  and  injected  into  guinea  pigs  for antibody production (Covance). Anti‐MCPH1 antibodies were affinity purified using standard techniques.    
Drosophila IVEC screen for APC substrates and APC­mediated degradation 




  p71,  p78,  or  p91  (MCPH1‐B)  coding  region  was  subcloned  into  a  pCS2 derivative encoding an N‐terminal GFP tag. The resulting constructs encoding GFP‐tagged  p71,  p78,  or  p91  were  transiently  transfected  into  NIH  3T3  cells  using Lipofectamine (Invitrogen) according to the manufacturer's protocol and examined by fluorescence microscopy.   
Drosophila protein extracts and immunoblots 
  Protein  extracts  were  made  by  homogenizing  embryos  (1‐2  hr  unless otherwise indicated) or dissected tissues in urea sample buffer as described (Moore et  al.  1998).  Proteins were  transferred  to nitrocellulose  for  immunoblotting using standard techniques.  The method of Edgar et al. (1994) was used to make extracts from  staged  syncytial  embryos  (ten  cycle‐10  embryos per  lane). Briefly, Methanol fixed  embryos  were  collected  (110‐140  minute)  and  stained  using  DAPI.    After clearing  on  ice  for  1  hour,  embryos  were  observed  using  a  10X  objective  and separated based on cycle number and cell‐cycle stage.  3X SDS buffer was added (2 µl/embryo),  and  samples  were  boiled  for  10  minutes.  Antibodies  were  used  as follows:  guinea  pig  anti‐MCPH1  (1:200‐500),  mouse  anti‐Cyclin  B  (F2F4,  1:200, Developmental Studies Hybridoma Bank), and mouse anti‐α‐tubulin (DM1α, 1:5000, Sigma). HRP‐conjugated secondary antibodies and chemiluminescence were used to detect primary antibodies. 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Quantification of embryonic hatch rates   For  hatch  rate  assays,  embryos  (0‐4  hr)  were  collected  on  grape  plates, counted, and aged ~40 hr at 25°C. The number of hatched embryos was determined by subtracting number of unhatched (intact) embryos from total number collected. Hatch rate is the ratio of hatched to total embryos expressed as a percentage. 
 
Cell culture extracts and immunoblots   HeLa  or  HEK293  cell  extracts  were  made  in  6‐well  dishes  by  removing media, washing once with  ice‐cold PBS, and adding 150 µl of non‐denaturing  lysis buffer.    After  30  minutes,  cells  were  scraped,  spun  down,  and  supernatant  was collected.    Protein  concentration  was  determined  by  Bradford  assay.    Lysates containing 10‐20 µg of protein were mixed with 3X SDS buffer and analyzed by SDS‐PAGE/Western blot.   Antibodies were used as  follows: rabbit anti‐hMCPH1 (2AB1, 1:200‐1:500),  rabbit  anti‐Cyclin  B  (1:500,  Santa  Cruz),  mouse  anti‐α‐Tubulin (DM1α, 1:5000, Sigma), mouse anti‐Cdk1 (PSTAIR, 1:1000, Millipore).  
Cell synchronization   HeLa cells were plated on a 10 cm dish at 40% confluency and treated with thymidine (2mM) for 24 hours.  Cells were washed twice with PBS and treated with nocodazole  (0.1µg/ml)  for  12‐14  hours.    After  removing  the  media,  plates  were firmly  tapped  to  loosen  the  rounded,  mitotic  cells  from  the  dish.    Cells  were collected  in  10  ml  serum‐free  media  by  centrifugation  for  5  minutes,  and resuspended  in  fresh  serum‐free media.    This was  repeated  five  times.    After  the 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final wash, cells were resuspended in media containing 10% FBS and plated at 50% confluency in the wells of a 6‐well dish.  Cells were collected as follows: media was removed  and  cells  washed  in  PBS.    100  µl  0.25%  trypsin‐EDTA  was  added  and neutralized with 1 ml media.  Cells were collected and washed once in PBS.  25% of each  sample  was  saved  for  FACS  analysis  while  the  remaining  cells  were resuspended  in  50  µl  NDLB  and  analyzed  by  SDS‐PAGE/Western  blot.  For  FACS, cells were fixed in 70% ethanol, stained with propidium iodide, and analyzed using a  5‐laser  BD  LSRII  located  in  the  Vanderbilt  University  Flow  Cytometry  Core Facility.     
In vivo ubiquitylation assay 
  hMCPH1,  hMCPH1‐KEN,  and  hMCPH1‐Dbox  were  subcloned  into  the  CS2+ vector  encoding an N‐terminal 6‐Myc  tag and  transfected  into HEK293 cells using Lipofectamine  (Invitrogen) with  or without  a  construct  encoding  histidine‐tagged ubiquitin  (PMT107,  Treier  et  al.,  1994).    40  hours  post‐transfection,  cells  were harvested  and  washed  two  times  in  PBS.    Cells  were  sonicated  in  Buffer  A  (6M guanidine‐HCl, 0.1M Na2HPO4/NaH2PO4, 10mM imidazole, pH 8.0) and  incubated with nickel agarose beads for three hours shaking at 4°C.   The beads were washed twice in Buffer A, twice in 1:3 Buffer A/TI, and once in Buffer TI (25 mM Tris‐HCl, 20 mM imidazole, pH 6.8).  Proteins bound to the beads were then released by boiling in 3X SDS for 10 minutes and analyzed by SDS‐PAGE/Western blot. 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Capped RNA synthesis   The RNA synthesis reaction was derived from patent 7,074,596.   Briefly, 20 μL in vitro transcription reactions contained 40 mM Tris‐HCl, pH 7.9, 6 mM MgCl2, 2 mM spermidine, 10 mM DTT, 2 μg BSA, 20 units of RNasin (Promega), 0.5 mM ATP, 0.5  mM  CTP,  0.5  mM  UTP,  0.1  mM  GTP,  1  mM  cap  analog  (GpppG,m7GpppG, m73'dGpppG, or m27,O3'GpppG, New England Biolabs), 1.0 μg DNA, and 20 units of SP6 polymerase (Promega).  cDNAs (Mos, GFP, human MCPH1, human MCPH1‐KEN, Drosophila MCPH1‐B, and Drosophila MCPH1‐A) subcloned into CS2+ and linearized with the NotI restriction enzyme were used for DNA source.   Human MCPH1 cDNA clones were obtained from Marc Kirschner’s lab (Harvard Medical School).  




  Immediately  after  injection,  embryos  were  analyzed  using  a  Zeiss  Stemi 2000‐CS stereoscope equipped with an Olympus DP72 camera.  Images of dividing embryos  were  captured  at  30  second  intervals  using  the  Olympus  DP2‐BSW software.  
Immunostaining of Xenopus embryos 




A  screen  for  substrates  of  the  Anaphase­Promoting  Complex  identifies 
Drosophila MCPH1   
  We  independently  identified  MCPH1  in  a  Drosophila  genome‐scale biochemical screen  for Anaphase‐Promoting Complex (APC) substrates. We used a previously described Drosophila IVEC (in vitro expression cloning) approach (Lee et al. 2005)  to screen  for  radiolabeled Drosophila proteins  that are degraded and/or phosphorylated  in  mitosis.  Our  design  was  based  on  previous  IVEC  screens  of Xenopus cDNA libraries (King et al. 1997; Lustig et al. 1997; McGarry and Kirschner 1998; Ayad et  al.  2005). APC substrates were  identified as bands  that decrease  in intensity in mitotic or Cdh1‐supplemented interphase Xenopus egg extracts.  Bands with decreased intensity in either of these reactions represent candidate APC‐Cdc20 or APC‐Cdh1 substrates,  respectively.   Mitotic kinase substrates were  identified as bands  with  reduced  gel  mobility  in  mitotic  extracts  (compared  to  interphase extracts).  We screened 5849 cDNA clones (~43% of the fly genome) in this manner. We  found  a  high  frequency  of  mitotic  phosphorylation  (roughly  one  positive  per pool of 24  clones).  In  contrast,  only  three pools had proteins  (p91, p78,  and p71) that degraded in Cdh1‐supplemented extracts; all  three exhibited upward mobility shifts  in mitotic extracts  (Figure 3.1A),  suggesting  that  they are substrates of both the APC‐Cdh1 and of mitotic kinases. 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localizationb  Vertebrate homolog p91  LD43341c  MCPH1  BRCT domaind  Nucleus  MCPH1 p78  GH13229  CG32982  PH domaine  Cytoplasm  None p71  LD21675  CG3679  Novel  Microtubules  None aDrosophila Gene Collection bBased on results shown in Figure 3.1C cEncodes isoform B of MCPH1 dBRCA1 C‐Terminal domain ePleckstrin homology domain 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 Individual cDNA clones encoding APC substrates were identified within each of the three positive pools (Table 3.1).  p91 is identical to MCPH1‐B. p78 and p71 are novel proteins, and BLAST searches revealed no obvious vertebrate homologs.  For all three, specificity of APC‐mediated degradation was shown by Cyclin competition: addition  of  N‐terminal  Cyclin  B  peptide  to  Cdh1‐supplemented  extracts  blocked their degradation (Figure 3.1B and data not shown). We assessed their subcellular localizations  by  transfecting  plasmids  encoding  GFP  fusions  of  the  Drosophila proteins  into  mammalian  cells.  MCPH1‐B,  p78,  and  p71  localized  to  the  nucleus, cytoplasm, and microtubules, respectively, of interphase cells (Figure 3.1C). 
 
MCPH1­B contains a functional  D box   Two MCPH1  isoforms, splice variants of  the same gene, exist  in Drosophila.  
mcph1­A encodes a protein that is structurally similar to human Microcephalin with a single N‐terminal BRCT domain and paired BRCT domains at the C‐terminus.  Only the N‐terminal BRCT domain is encoded within mcph1­B and the protein terminates just before  the  start of  the paired domains.   Alternative  splicing also  results  in an extra 40 amino acids at the amino terminus of MCPH1‐B (Figure 3.2A).  To identify the signal within MCPH1 that mediates  its  turnover, we  looked  for sequences  that might  represent  the  two major  degradation  signals  recognized  by  APC‐Cdh1:  the destruction  box  (D  box)  (Glotzer  et  al.  1991)  and  the  KEN  box  (Pfleger  and Kirschner  2000). MCPH1‐B  contains  several  candidate D  box  sequences  (data  not shown) but no KEN boxes. We found that MCPH1‐A is not significantly degraded in Cdh1‐supplemented Xenopus extracts (Figure 3.2B), suggesting that the critical D  
  75 
 
Figure 3.2.  Identification of  the  critical destruction box within MCPH1­B.  (A) Comparison of MCPH1 isoforms reveals differences in the N‐terminus including the presence (MCPH1‐B) or absence (MCPH1‐A) of a putative D box sequence.   Human MCPH1 contains four putative D boxes as well as a KEN box. (B) Cdh1‐supplemented extracts  degrade  MCPH1‐B,  but  not  MCPH1‐A.    (C)  Radiolabeled  MCPH1‐B (untagged, Myc‐tagged, or mutated) was added to Xenopus interphase egg extracts (minus  or  plus  Cdh1)  and  reaction  products  analyzed  by  SDS‐PAGE/autoradiography. Cdh1‐supplemented extracts degrade full‐length, untagged MCPH1‐B. MCPH1‐B proteins with  the  following modifications were  tested  in  this assay: Myc‐tagged at  the amino or carboxy  terminus  (Myc‐MCPH1‐B or MCPH1‐B‐Myc,  respectively),  N‐terminal  deletion  of  40  amino  acids  (DeltaN‐MCPH1‐B),  or mutation of destruction box within this N‐terminal region (DeltaDbox‐MCPH1‐B). 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box lies in the N‐ or C‐terminal regions of MCPH1‐B that differ from MCPH1‐A.  Myc tagging the amino terminus of MCPH1‐B rendered it resistant to APC‐Cdh1, whereas tagging the carboxy terminus had no effect on stability (Figure 3.2C).  These results suggest that the critical D box lies near the amino terminus of MCPH1‐B.  Removal of its  N‐terminal  40  amino  acids  or  specific  mutation  of  a  candidate  D  box  in  this region  resulted  in  its  stabilization  in  Cdh1‐supplemented  extracts  (Figure  3.2C), confirming that we have identified the critical D box of MCPH1‐B.   
Drosophila MCPH1­B is an in vivo substrate of the Anaphase Promoting 
Complex   If MCPH1‐B were an in vivo substrate of APC‐Cdh1, its levels should fluctuate in a cell‐cycle dependent manner. Immunoblotting of extracts from staged syncytial embryos revealed that MCPH1 levels are lower in interphase than in mitosis (Figure 3.3A).  This  type  of  pattern  parallels  that  of  the  iconic  APC  substrate,  Cyclin  B,  in syncytial embryos (Edgar et al. 1994). Consistent with our observation that MCPH1 is  phosphorylated  in  Xenopus mitotic  extracts,  we  observe  an  upward  shift  in  its mobility on immunoblots of early mitotic embryos .   We  further  used  a  genetic  approach  to  examine MCPH1  levels  in  embryos derived from APC2 (morula or mr) mutant females.  mr encodes the Cullin‐homology domain subunit of the APC and is essential for ubiquitin ligase function.  Similar to a known APC substrate, Cyclin B, MCPH1 levels are higher in 0‐1hr embryos derived from mr  females  (Figure  3.3B).    These  embryos  arrest  soon  after  the  start  of  the syncytial divisions, so to test whether this difference in MCPH1 levels is due to the 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Figure  3.3.  Drosophila  MCPH1­B  is  an  in  vivo  APC  substrate.  (A‐B)  MCPH1 immunoblots.  (A)  A  comparison  of  interphase  and  metaphase  embryo  extracts reveals  higher  levels  of  MCPH1  during  mitosis.  (B)  Higher  MCPH1  and  Cyclin  B levels  are  present  in morula  mutant  background.  (C)  Localization  of  endogenous MCPH1  within  wild‐type  eye  imaginal  disc  by  immunofluorescence.    Arrowhead indicates morphogenetic  furrow.    A  band  of  cells  at  G2/M  are  visible  behind  the furrow in the posterior half of the disc.  Asynchronously dividing cells are present in front  of  the  furrow  in  the  anterior  half.    Eye  imaginal  disc  diagram  adapted  from Araki  et  al.  (2005).  (D)  Spindle  from  embryo  overexpressing  MCPH1.    Tubulin (green) and DNA (red). 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age  of  the  embryos,  we  compared  MCPH1  levels  in  wild  type  embryos  over  the course  of  an  hour.    No  differences  in MCPH1  levels were  observed  between  0‐15 min, 15‐30 min, 30‐45 min, and 45‐60 min embryos (data not shown).   We  also  examined  MCPH1  localization  within  the  eye  imaginal  discs  of Drosophila third instar larvae.  In this system, as the morphogenetic furrow moves in  a  posterior  to  anterior  direction,  cells  are  synchronized;  G1  cells  are  present within the furrow, followed by stripes of G2/M and S phase cells (Figure 3.3C).  APC substrates,  because  they  are  degraded  during  late  M  and  G1,  are  not  observed within the morphogenetic furrow. In wild‐type discs, MCPH1 and Cyclin B localize to G2/M cells (Figure 3.3C and data not shown).     To  assess  the  biological  importance  of  MCPH1  oscillations,  we  generated transgenic  flies to express MCPH1‐B with an RXXL to AXXL mutation  in the D box.  This non‐degradable MCPH1 is functional because it rescues an mcph1 mutant with a  95%  embryo  hatch  rate.    To  determine  if  stabilization  of  MCPH1  causes developmental  effects,  we  compared  the  embryonic  hatch  rate  of  several  MCPH1 and  MCPH1‐Dbox  transgenic  lines.    Seven  lines  each  were  used;  however,  hatch rates varied greatly within each group suggesting  that  the effects of  chromosomal insertion  mask  any  developmental  effects  that  exist.    We  were  precluded  from making transgenes with the same insertion site because the constructs do not exist for UASp‐type vectors.   Syncytial embryos expressing high Myc‐MCPH1 levels have aberrant  spindles  resembling  those  of mcph1  loss‐of‐function mutants  suggesting proper control of MCPH1 levels during early embryogenesis is critical for cell‐cycle 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progression  (Figure  3.3D).    It  remains  to  be  determined  if  the  inability  of  APC  to degrade MCPH1 present at more physiological levels affects embryo development.   
 
Human Microcephalin is degraded in a Cdh1­dependent manner 
  We next  sought  to  determine  if  APC  regulation  of MCPH1  is  evolutionarily conserved.    Human  and  Drosophila  MCPH1  share  only  16%  identity  overall  and 38%  identity  of  their  N‐terminal  BRCT  domains.  Using  the  same  Xenopus  extract degradation  assay,  we  found  that  human  MCPH1  is  degraded  in  an  APC‐Cdh1‐dependent manner but remains stable in APC‐Cdc20/mitotic extracts (Figure 3.4A).  As  a  control,  Cyclin  B,  a  known  substrate  of  both  APC‐Cdc20  and  APC‐Cdh1,  is degraded  in  both  extracts  as  expected.    Similar  to  Drosophila  MCPH1,  a mobility shift occurs in CycBΔ90‐supplemented (mitotic) extracts.    APC  substrates  oscillate  in  abundance  during  the  cell  cycle  with  levels highest  in  G2/M  and  lowest  in  G1.    By  Western  analysis  and  using  antibodies generated against human MCPH1, we examined MCPH1 over a 24‐hour time period in HeLa cells synchronized using a nocodazole block and release.  Similar to Cyclin B, MCPH1  levels  are  highest  during mitosis  after  nocodazole  release.    Once  the  cells enter G1 after 3‐4 hours, protein levels drop but begin to rise again during S phase 16  hours  post‐release  (Figure  3.4B).    To  confirm  cell  synchronization,  cells  from each time point were fixed and analyzed for DNA content by FACS (data not shown). 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Identification of a functional KEN box in human MCPH1   We  identified  putative  destruction  sequences,  four  D  boxes  and  one  KEN sequence, within human MCPH1  (Figure 3.2A).   Recognition of  a KEN  sequence  is specific  to  APC‐Cdh1,  and  human  MCPH1  degrades  in  an  APC‐Cdh1  dependent manner.    Thus,  we  hypothesized  that  mutation  of  the  KEN  sequence  to  alanines would  stabilize  the  protein.    In  Xenopus  extracts  supplemented  with  Cdh1,  the MCPH1 KEN mutant remains stable over time compared to wild type. We also tested the  functionality  of  the  first  putative D  box;  however,  an RXXL  to AXXA mutation does  not  stabilize  the  protein  nor  does  it  enhance  stability  when  the  KEN  box  is mutated (Figure 3.4A).   
MCPH1 is ubiquitinated in human cells 




Figure  3.4.  Human  MCPH1  is  an  APC  substrate.    (A)  APC‐mediated  protein degradation assays. Radiolabeled proteins were  incubated in Xenopus egg extracts and reaction products analyzed by SDS‐PAGE/autoradiography.  MCPH1 degrades in a  Cdh1‐dependent  manner  while  a  Cyclin  B  control  degrades  in  both  APC‐Cdc20 (+CycBΔ90 extracts) and APC‐Cdh1 extracts.  Mutation of the KEN degradation box to alanines stabilizes the protein while mutation of the first putative Dbox does not. (B) Endogenous levels of MCPH1 in nocodazole‐synchronized HeLa cells over time.  Higher  protein  levels  in mitosis  after  nocodazole  release  (0‐2  hours).    Decreased levels  are  apparent  during  G1  (hours  4‐14)  but  levels  begin  to  rise  again  in  S through the following G2/M (hours 16‐22).  A Cyclin B control has a similar pattern. (C)  HEK293  cells  transfected  with  Myc‐MCPH1  and  His‐Ub  reveal  ubiquitylated protein. 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is required to determine if mutation of all D boxes and the KEN sequence is required to stabilize MCPH1 in vivo.  
Overexpression of MCPH1 leads to cell­cycle arrest   Previously, we determined that overexpression of MCPH1 leads to cell‐cycle arrest  in  Drosophila  embryos.    We  next  wanted  to  determine  if  vertebrate development was also affected in the presence of excess MCPH1.  2‐ or 4‐cell stage Xenopus  embryos  were  injected  with  MCPH1  in  one  half  of  the  embryo.    As  a control,  embryos were  injected with Mos,  a  strong  inhibitor of Cdk1  function  that prevents  the  injected  cells  from dividing more  than one  time  (Figure 3.5A).   GFP‐injected  embryos  served  as  a  negative  control  and  were  indistinguishable  from those that were uninjected (Figure 3.5A).  Injection of human MCPH1 results in cell‐cycle  arrest  or  delay  in  92%  of  embryos  (Figure  3.5B).    Injection  of  either Drosophila MCPH1‐B or MCPH1‐A RNA  results  in  67% and 30% of  embryos with cell‐cycle progression defects,  respectively (Figure 3.5B).   Live  imaging of MCPH1‐injected embryos revealed cells that appear to divide normally for the first few cell cycles  followed  by  attempted  divisions  where  a  cleavage  furrow  forms  but eventually disappears.      The  absence  of  MCPH1  leads  to  premature  chromosome  condensation defects  in human cells,  and  in Drosophila,  chromatin bridging occurs at  anaphase.  We hypothesized that the presence of too much MCPH1 also leads to chromosomal aberrations and subsequent cell‐cycle arrest.  By immunofluorescence, we localized Tubulin  as  well  as  DNA  within  MCPH1‐injected  embryos  fixed  four  hours  post‐
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 We  identified  Drosophila MCPH1  as well  as  two  other  novel  proteins,  p78 and p71, in a biochemical DIVEC screen for substrates of the APC.  Previous screens for  vertebrate  substrates  of  the  APC  that  employed  a  similar  IVEC  approach successfully  identified  key  cell‐cycle  regulators,  including Geminin,  an  inhibitor  of DNA  replication  (McGarry  and  Kirschner  1998),  Securin,  an  inhibitor  of  sister‐chromatid separation (Zou et al. 1999), Tome‐1, a trigger of mitotic entry (Ayad et al. 2003), and Sororin, a mediator of sister‐chromatid cohesion (Rankin et al. 2005).  Our  data  indicate  that  Drosophila  MCPH1  degrades  in  an  APC‐Cdh1‐dependent manner  while  remaining  stable  in  mitotic  extracts  when  APC‐Cdc20  is  activated.  The first putative D‐box within the MCPH1‐B protein structure is sufficient for APC‐mediated degradation.   By genetic analysis, we found that mutations in Drosophila 
morula, which encodes the homolog of the vertebrate APC2 subunit, renders MCPH1 stable.  MCPH1 protein also cycles in the early embryo with highest levels in mitosis.   We  further  discovered  that  human MCPH1  degrades  in  a  Cdh1‐dependent manner,  and  endogenous protein  levels  in  cultured HeLa  cells  fluctuate  similar  to other  APC  substrates.    Mutation  of  the  KEN  box  alone  confers  stability  in  the biochemical  extract  system;  however,  this  was  not  the  case  in  an  in  vivo ubiquitination assay or when Myc‐tagged constructs were co‐transfected with Cdh1.  Besides  the KEN box, human MCPH1 contains  four putative D boxes.    Several APC substrates  that  contain  multiple  degrons  have  been  identified  including  Securin, Shugoshin,  Cdc6,  and Nek2A  (Zur  and Brandeis,  2001)  (Karamysheva  et  al,  2008) 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(Mailand  and Diffley,  2005)  (Hayes  et  al.  2006).    Thus,  it  is  possible  that multiple degrons  within  human  MCPH1  are  recognized  in  vivo.    Our  results  indicate  that mutation of each D‐box singly in addition to the KEN box does not stabilize MCPH1; therefore,  a  more  thorough  examination  is  in  order  to  test  every  combination  of mutated degrons.   Finally, our data indicate that excess levels of MCPH1 cause cell‐cycle arrest as  evidenced  by  injection  of  Xenopus  embryos  with  either  human  or  Drosophila 
MCPH1  RNA.    Arrested  cells  contain  multiple,  free‐floating  centrosomes,  and  any DNA  present  has  an  appearance  of  aneuploidy  and  is  strewn  between  cells.  Interestingly,  in  early  Drosophila  syncytial  embryos,  overexpression  of  MCPH1‐B results in cell‐cycle arrest similar to the mcph1 null mutation, though the percentage of  arrested  embryos  seems  to  be  dependent  upon  the  level  of  overexpression (Rickmyre et al. 2007 and Chapter 2).    In each case,  triggering of  the centrosomal inactivation  pathway,  a  Checkpoint  kinase  2‐mediated  event,  appears  to  be  the cause of the mitotic arrest.   Our data is in accordance with previous studies that suggest under‐ or over‐expression  of MCPH1  leads  to  cell‐cycle  defects.    In MCPH1  null  or  siRNA‐treated cells,  premature  chromosome  condensation  defects  occur  as  well  as  a  failure  to timely decondense chromatin after mitosis (Trimborn et al., 2004).  Additionally, in the presence of DNA damage,  in particular, double‐stranded DNA breaks,  cells are unable  to  respond  properly  to  initiate  repair  (Lin  et  al.,  2005;  Wu  et  al.,  2009).  Interestingly, too much MCPH1 resulting from a chromosomal duplication has been implicated in cases of autism (Glancy et al., 2009; Ozgen et al., 2009).  These changes 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in MCPH1 levels are detrimental to embryonic development, and our current study indicates  that  even  small  fluctuations  of  MCPH1  protein  levels,  as  caused  by regulation of the APC and 26S proteasome, may be important to promote proper cell cycles.    We propose a simple model  for APC regulation of MCPH1  levels during  the cell  cycle.   During S and G2, when APC  is not active, MCPH1  levels  rise  to prevent premature  chromosome  condensation  and  early  activation  of  Condensin  II complexes.    During  mitosis,  we  hypothesize  inhibitory  phospho‐regulation  of MCPH1  occurs  during  prophase,  allowing  Condensin  II  activity  and  appropriate chromosome condensation.  MCPH1 is not degraded early in an APC‐Cdc20 manner because  proper  decondensation  at  the  end  of  mitosis  also  requires  MCPH1.    Our overexpression  studies  in  Drosophila  and  Xenopus  suggest  excessive  MCPH1 induces  genomic  instability;  therefore  MCPH1  is  downregulated  in  an  APC‐Cdh1 dependent manner during G1 though never fully degraded.   This allows MCPH1 to continue  to  perform  its  other  function  as  a  genomic  scaffold  to  bring  in  repair proteins to sites of DNA damage.   From  an  evolutionary  standpoint,  our  data  suggest  that  APC  regulation  of MCPH1 is important from Drosophila to human.   Intriguingly, humans have evolved an additional APC recognition sequence, the KEN box.   A database search for other vertebrate MCPH1  sequences  reveals  a  similarly  positioned  KEN  box within  their respective MCPH1 proteins.   Unexpectedly,  the C.  elegans  homolog of MCPH1 also contains a KEN box,  though its  location within the protein  is not similar to human and other vertebrates.   Whether any of these KEN box are functional remains to be 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 We  previously  identified  MCPH1  in  two  independent  screens:  one  for regulators of the early syncytial cycles in Drosophila and the other for substrates of the Anaphase Promoting Complex or APC.  In the absence of MCPH1, embryos arrest with  barrel‐shaped  spindles,  lacking  centrosomes.    This  phenotype  was  due  to triggering  of  centrosomal  inactivation,  a  Checkpoint  Kinase  2‐mediated  response that  occurs  in  the  early  embryo  in  the  presence  of  DNA  damage  or  incomplete replication.    A  primary  defect  observed  in  embryos  from null mcph1  females was chromatin  bridging  after  the  onset  of  anaphase.    In  addition  to  MCPH1,  the Drosophila  homologs  of  Checkpoint  Kinase  1  and  ATR,  or  Grapes  and  Mei‐41, respectively, also caused centrosomal inactivation.  Studies of human MCPH1 placed the protein within the ATR/Chk1 response to DNA damage.  We found no apparent role for Drosophila MCPH1, however, within the ATR/Chk1 pathway.  In an effort to understand  the  role  MCPH1  plays  during  embryogenesis,  we  performed  tandem affinity  purification/mass  spectrometry  of  MCPH1  complexes  from  the  early Drosophila embryo.   Tandem  affinity  purification  or  TAP  provides  an  effective  strategy  for  the purification  of  protein  complexes  under  non‐denaturing  conditions.  These 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complexes  can  then  be  trypsinized  and  analyzed  by  liquid  chromatography  and tandem mass  spectrometry  (Gould  et  al.  2004).      A  typical  TAP  tag  consists  of  a Calmodulin  binding  protein  (CBP)  and  two  Staphylococcus  aureus  Protein  A  IgG binding  proteins.    The  Protein  A  and  CBP  are  separated  by  a  TEV  cleavage  site allowing  two  rounds  of  purification  of  protein  complexes  within  a  reasonable amount of time (Puig et al., 2001).  This type of approach was first used in budding yeast  due  to  the  ease  of  culturing  large  volumes of  eukaryotic  cells  expressing  an epitope‐tagged protein of interest.  TAP has since been adapted for use in a variety of  systems,  from  mammalian  cell  culture  to  whole  organisms  like  Drosophila,  in which  the UAS‐Gal4  system was used  to  express  tagged  components  of  the Notch signaling  pathway  in  Drosophila  embryos  in  an  effort  to  identify  new  pathway components (Veraksa et al. 2005).    Several studies have identified interactors of human MCPH1 through affinity purification/mass  spectrometry.    Intriguingly,  the  majority  of  these  reported interactors  are  involved  in  chromatin modification.    In  one  study,  each  subunit  of the  Condensin  II  complex,  a  regulator  of  chromosome  condensation  at  prophase, was  co‐purified  with  MCPH1  (Wood  et  al.,  2008).    Another  study  discovered subunits  of  SWI‐SNF,  an  ATP‐driven  chromatin  remodeling  complex  that  relaxes chromatin at sites of DNA damage (Peng et al., 2009).  Our study would be the first in  which  MCPH1‐containing  protein  complexes  would  be  purified  from  a  whole organism and at a stage  in which MCPH1  is absolutely critical  to prevent genomic instability.  Thus,  we  hypothesized  that  our  screen  for  interactors  of  Drosophila MCPH1 would yield a subset of proteins not previously reported by other groups. 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 Here we present the findings from our screen for interactors of MCPH1‐B, an isoform of mcph1 that codes for a single N‐terminal BRCT domain in the protein.  In contrast,  human  MCPH1  contains  three  BRCT  domains:  one  N‐terminal  and  two tandem C‐terminal domains.   Many of our hits are proteins  involved  in  chromatin modification,.    Intriguingly,  human  MCPH1  studies  have  reported  that  the  N‐terminal  BRCT  domain  is  critical  to  prevent  untimely  chromosome  condensation (Wood et al., 2008; Richards et al., 2009).   Our screen has also revealed subsets of proteins  involved  in  RNAi‐mediated  silencing  and  spindle  integrity  that  have  not previously been reported to interact with MCPH1.  Of particular interest, Abnormal Spindle,  the Drosophila homolog of another human microcephaly gene, ASPM, was identified and confirmed to directly bind MCPH1.  
METHODS 
 
Drosophila stocks   Flies were maintained at 25˚C using standard techniques (Greenspan 2004). Wild‐type  stocks  used  were  y  w.    nanos­Gal4:VP16  and  actin5C­Gal4  stocks  were obtained from the Bloomington Stock Center.     
cDNA clones and transgenes  A cDNA clone encoding MCPH1‐B (LD43341) was from the Drosophila Gene Collection.    A  cDNA  clone  encoding  Drosophila  Axin  was  a  gift  from  Ethan  Lee.  MCPH1‐B  or  Axin  coding  region was  subcloned  into  a  UASp  vector  (Rorth  1998) 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modified  with  a  C‐terminal  TAP  tag  or  a  derivative  encoding  six  N‐terminal  Myc tags.    UASp­Myc‐MCPH1­B,  UASp­MCPH1­B­TAP,  and  UASp­Axin­TAP  were transformed into y w flies as described (Spradling 1986).   
Polyclonal antibodies against Drosophila MCPH1 
  MBP fused to MCPH1‐B (N‐terminal 352 amino acids) was used to produce antibodies.  N‐terminal MCPH1‐B  sequence was  PCR‐amplified  from  LD43341  and subcloned  into  pMAL  (New  England  Biolabs).  MBP‐N‐MCPH1‐B  was  made  in bacterial  cells,  purified  using  amylose  beads,  and  injected  into  guinea  pigs  for antibody production (Covance). Anti‐MCPH1 antibodies were affinity purified using standard techniques.  




  Salivary  glands  from  third  instar, wandering  larvae  (those  crawling  on  the sides of the bottle) were dissected in PBS, soaked in 45% acetic acid for 1 minute, and  lightly  squashed  in 15 µl 45% acetic  acid on a  slide.  Slides were  immediately frozen in liquid nitrogen and the cover slip was removed.  The slide with the tissue was soaked in absolute ethanol at ‐20°C for 30 minutes.  The slide was then washed in  PBS‐T  and  stained  using  anti‐mouse  Myc  (1:500,  9E10,  Sigma).    Secondary antibodies conjugated to Cy2 were used (1:500) and samples were visualized using a Nikon Eclipse 80j microscope equipped with a PlanFluor 40x objective lens and a Photometrics CoolSnap ES camera. 
 
Quantification of embryonic hatch rates   For  hatch  rate  assays,  embryos  (0‐4  hr)  were  collected  on  grape  plates, counted, and aged ~40 hr at 25°C. The number of hatched embryos was determined by subtracting number of unhatched (intact) embryos from total number collected. Hatch rate is the ratio of hatched to total embryos expressed as a percentage. 
 
Collection of embryos for TAP 
  UASp­MCPH1­B­TAP  or  UASp­dAxin­TAP  flies  were  crossed  to  nanos‐
Gal4:VP16 flies in forty bottles each.  After 15 days, flies from all of the bottles were divided into two large collection chambers.  Styrofoam trays with a grape juice agar and  a  thin  layer  of  yeast  paste  were  placed  in  the  chambers  and  used  to  collect embryos (0‐3 hours).  For each purification, 1.5 grams of embryos were used. 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Tandem affinity purification and mass spectrometry of complexes 





   We  examined  whether  Drosophila  MCPH1  exists  in  a  larger  molecular weight complex by sucrose density gradient.   Myc‐tagged MCPH1‐B was expressed in early Drosophila embryos.  This fusion is functional because it can rescue the null 
mcph1 mutation.  A peak of low molecular weight (~118 kDa)  occurs in fractions 2‐5,  likely  representing  Myc‐MCPH1  unbound  to  other  proteins  (Figure  4.1A).    A second  prominent  peak  occurs  in  fractions  14‐15,  corresponding  to  a  complex greater than 440 kDa, suggesting that MCPH1 exists in a larger complex of proteins (Figure 4.1A).    In  an  effort  to  understand  the  molecular  framework  in  which  MCPH1 participates,  we  screened  for  proteins  that  exist  in  complex with MCPH1  using  a tandem  affinity  purification/mass  spectrometry  approach.    Similar  studies  have been performed using human or mouse cells in culture; however, our system is the first  in which  a whole  organism was  used,  the  early Drosophila  embryo.    The  tag used  to  purify  complexes  was  the  C‐terminal  TAP.  We  chose  a  C‐terminal  tag because our data suggest MCPH1 is a substrate of the Anaphase Promoting Complex, and N‐terminally tagging the protein prevents APC from recognizing MCPH1 in our 
in  vitro  assay.    Using  the  UASp‐Gal4  system,  we  expressed  MCPH1‐B‐TAP  in  the ovaries and early embryos of Drosophila by driving Gal4 protein synthesis with the 
nanos  gene promoter.   By Western analysis, we determined  that MCPH1‐TAP was expressed  at  a  level  approximately  twice  that  of  wild‐type MCPH1  (Figure  4.1B). 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Figure  4.1. MCPH1  exists  in  a  high molecular weight  complex.    (A)  Fractions from  a  sucrose  density  gradient  reveal MCPH1  exists  in  a  large molecular weight complex, fractions 13‐18 (>440 kDa).  The first peak, fractions 1‐5, likely represent Myc‐MCPH1  alone.    GAPDH  was  used  as  a  control  for  a  non‐complex  forming protein.  (B) MCPH1‐TAP expresses in early embryos at approximately twice that of endogenous MCPH1.  (C) MCPH1 is highly purified after tandem affinity purification.  (D) Purified complexes were analyzed by SDS‐PAGE and silver stained. 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highlighted in green, and a brief description of cellular function is listed for each hit if  known  (Table  4.1).    Our  screen  for  MCPH1‐binding  proteins  revealed  several interesting  interactors, many  of which  can  be  narrowed  into  one  of  the  following categories  of  cellular  function:  chromatin  remodeling,  RNAi  components,  DNA damage response and repair, and spindle integrity.   
 
MCPH1­B localizes to euchromatin in Drosophila larval salivary glands 








Count Cellular role References 
MCPH1-B 55.20% 2042 genomic stability (Rickmyre et al., 2007) 
Histone H4 35.90% 21 chromatin integrity; nucleosomes (Khorasanizadeh, 2004) 
Histone H3 27.90% 5 chromatin integrity; nucleosomes (Khorasanizadeh, 2004) 
Maternal expression at 
31B 24.90% 75 
RNAi silencing; component of 
nuage processing body (Lim et al., 2009) 
Argonaute 2 16.30% 27 
associates with RISC, siRNA 
silencing (Okamura et al., 2004) 
Ballchen/NHK-1 15.30% 75 
histone H2A kinase; chromosome 
structure (Ivanovska et al., 2005) 
Histone H2Av 14.20% 7 
Histone H2A variant; becomes 
phosphorylated at sites of dsDNA 
breaks (Ivanovska et al., 2005) 
Protein on Ecdysone Puffs 14.10% 38 salivary gland transcription (Reim et al.,1999) 
Rm62 13.50% 21 
RNAi silencing; genetic interactor 
of FMR1 (Cziko et al., 2009) 
Otefin 13.00% 8 
germline stem cell maintenance; 






Count Cellular role References 
Origin recognition 
complex subunit 4 12.40% 13  Pre-replication complex  (Duncker et al., 2009) 
origin recognition 
complex subunit 1 11.90% 36  Pre-replication complex  (Duncker et al., 2009) 
Reptin 11.90% 9 chromatin remodeling (Jha and Dutta, 2009) 
Origin recognition 
complex subunit 5 10.90% 18  Pre-replication complex  (Duncker et al., 2009) 
Topoisomerase II 9.80% 48 
chromosome condensation; 
homologous pairing 
(Lupo et al., 2001; Williams et 
al., 2007) 
Replication Factor C 
subunit 4 9.40% 8 cell cycle checkpoint (Krause et al., 2001) 
Smc2 9.40% 18 Condensin core component (reviewed in Hirano, 2005) 
Abnormal Spindle 9.00% 66 spindle integrity; mcph gene 
(do Carmo Avides and Glover, 
1999; Riparbelli et al., 2001) 
14-3-3epsilon 8.80% 5 DNA damage checkpoint (Su et al., 2001) 
SMC4 (Gluon) 8.60% 20 Condensin core component (reviewed in Hirano, 2005) 
Zn72D 8.20% 11 mRNA binding; splicing 
(Worringer and Panning, 
2007) 
FMR1 8.10% 13 
translational repression via 
miRNA 
(reviewed in Zhang and 
Broadie, 2005) 
Origin recognition 






Count Cellular role References 
Lodestar 7.80% 15 
DNA binding; chromosome 
integrity (Girdham and Glover, 1991) 
DEAD box protein 73D 7.50% 6 RNA helicase (Patterson et al., 1992) 
Decapping protein 1 7.50% 4 
RNAi silencing; component of 
nuage processing body (Lim et al., 2009) 
Fascetto 7.50% 16 central spindle integrity (Verni et al., 2004) 
La related protein 6.10% 32 
syncytial embryo mitosis; male 
meiosis (Blagden et al., 2009) 
RacGAP50 6.10% 8 
central spindle 
integrity/cytokinesis (D'Avino et al., 2006) 
Suppressor of Variegation 
3-7 6.10% 22 heterochromatin silencing (Bushey and Locke, 2004) 
CapG 5.80% 7 Condensin I component (reviewed in Hirano, 2005) 
PAV-KLP protein 5.80% 8 
central spindle 
integrity/cytokinesis (Delcros et al., 2006) 
Pontin 5.70% 8 chromatin remodeling (Jha and Dutta, 2009) 
XRCC1 4.90% 5 DNA repair (Taylor et al. 2000) 
Origin recognition 
complex subunit 2 4.40% 4  Pre-replication complex  (Duncker et al., 2009) 
ATM/Tefu 3.90% 7 
DNA damage checkpoint; 






Count Cellular role References 
DISCO interacting protein 
(DIP1) 3.90% 2 
double-stranded RNA binding; 
mRNA control (DeSousa et al., 2003) 
CapD2 3.60% 16 Condensin I component (reviewed in Hirano, 2005) 
Smaug 3.50% 11 mRNA destabilization (Tadros et al., 2007) 
Ataxin-2 3.30% 2 miRNA silencing 
(Satterfield and Pallanck, 
2006) 
DNA ligase III 3.30% 2 DNA ligase n/a 
No-on-transient A protein 
form I 3.10% 7 
salivary gland transcription; 
localized to puffs (Reim et al.,1999) 
Slow as Molasses 3.10% 15 
mRNA localization; germ cell 
migration (Stein et al., 2002) 
Aubergine 3.00% 2 piRNA silencing 
(reviewed in Klattenhoff and 
Theurkauf, 2008) 
Topoisomerase III 2.90% 3 
generates single strand DNA 
breaks (Wilson-Sali and Hsieh, 2002) 
PIWI 2.60% 7 piRNA silencing 
(reviewed in Klattenhoff and 
Theurkauf, 2008) 
Pacman 2.40% 14 
RNAi silencing; component of 
nuage processing body (Lim et al., 2009) 
Ino80 2.30% 6 chomatin remodeling (Morrison and Shen, 2009) 
WOC protein 2.00% 7 
transcription factor; telomere 






Count Cellular role References 
dMi-2 protein 1.90% 5 chromatin remodeling (Bouazoune et al., 2002) 
Slender lobes 1.70% 4 
mushroom body development; 
nucleolar organization (Orihara-Ono et al., 2005) 
Sallimus 0.10% 2 chromosome structure (Machado and Andrew, 2000)  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UASp‐Myc‐tagged  MCPH1  in  Drosophila  salivary  glands  using  an  Actin‐Gal4 promoter.  Upon immunostaining for the Myc tag, we found MCPH1 to be specifically localized to the dark bands of polytene chromosomes (Figure 4.2).   




Figure  4.2.  MCPH1  localizes  to  less  condensed  regions  of  larval  polytene 






DISCUSSION    We  have  performed  a  screen  for  interactors  of  MCPH1  using  a  tandem affinity  purification/mass  spectrometry  approach.    Similar  studies  have  been carried out using human or mouse MCPH1, though full lists of interactors have not been  reported.    We  also  discovered  that  MCPH1  localizes  to  regions  of  open chromatin on Drosophila polytene chromosomes.   This  is  intriguing because many of  the proteins  found  in  the  screen also  interact with  chromatin.    From studies of human MCPH1, one could speculate that MCPH1 plays a role as a genomic director or  mediator,  bringing  together  components  from  multiple  pathways,  such  as chromatin  remodeling  complexes  or  repair  enzymes,  to  a  common  site  on  the chromatin.   
  Our study revealed several  interactors that have been identified in complex with vertebrate MCPH1 such as components of the Condensin complex, suggesting evolutionary conservation of function between human and Drosophila MCPH1.  The difference,  however,  is  that  we  found  Condensin  I‐specific  components,  while previous  screens  identified Condensin  II‐specific  components.   We  found  the  core components, SMC2 and SMC4, that are found in both Condensin I and Condensin II, and two out of  the three remaining Condensin I components, CapD2 and CapG.    In vertebrates,  nuclear  Condensin  II  acts  early  and  begins  to  condense  the chromosomes in prophase (reviewed in Hirano, 2005).  Drosophila Condensin I has been  shown  to  perform  this  same  function  (Oliveira  et  al.,  2007).    Furthermore, Drosophila Condensin II appears to be dispensable for this purpose but participates 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in  the  individualization  or  resolution  of  sister  chromatids  prior  to  the  onset  of anaphase (Oliveira et al., 2007; Hartl et al., 2008).   
  In  addition  to  the  Condensin  I  components,  we  discovered  many  proteins involved directly in chromatin modifications.  Topoisomerase II, an enzyme involved in  the  decatenation  of  DNA,  was  identified  in  both  MCPH1‐TAP  screens  with comparatively high sequence coverage.   Also, several other modifiers of chromatin structure  such  as  Pontin,  Reptin,  and  INO80  were  found  in  addition  to  core components of nucleosomes: H3, H4, and the histone variant H2AV.  Taken together, these results confirm previous studies of the involvement of MCPH1 in chromosome condensation and chromatin architecture while adding potential new players.   Our screen also revealed previously undescribed pathways in which MCPH1 may function, including a surprising number of components of RNAi pathways.  This includes  components  of  siRNA‐,  miRNA‐,  and  piRNA‐mediated  silencing.    Two particularly  strong  hits  were  Argonaute  2,  a  core  component  in  siRNA  silencing (Okamura et al., 2004) and Maternal Expression at 31B, a component found in RNAi processing centers (Lim et al., 2009).  Argonaute‐2 is at the core of siRNA silencing, helping  to  target  the  heterochromatin  protein,  HP1  to  the  heterochromatin  in centromeres  or  telomeres  (Djupedal  and  Ekwall,  2009)  Interestingly,  our  screen also revealed other telomeric proteins such as WOC and Suppressor of Variegation 3‐7.     Furthermore, five out of six subunits of the Origin Replication Complex were identified.    In  Drosophila,  ORCs  bind  chromatin  during  anaphase  when  it  is hypothesized  that  they  are  necessary  to  begin  to  set  replication  origin  sites 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(Baldinger  and  Gossen,  2009).    In  Orc2  and  Orc5  mutants,  chromosome condensation defects arise as a result of fewer origins (Pflumm and Botchan, 2001).  We hypothesize that MCPH1 promotes chromatin relaxation, allowing components, such as the ORCs, access to the chromatin.  
  We were  somewhat  surprised  to  find  interactors  that  are  involved  in DNA repair  because  our  screen  utilized  the  B  isoform  of MCPH1  that  does  not  contain tandem  BRCT  domains  in  the  carboxy  terminus.    Studies  of  human MCPH1  have shown that the paired domains are important for MCPH1 localization to sites of DNA damage.  We did not find any previously reported interactors such as BRCA2, Rad51, and  Chk1  (Wu  et  al.,  2009;  Alderton  et  al.,  2006).    Our  results  revealed  proteins involved in checkpoints (ATM, 14‐3‐3ε, and Replication Factor C subunit 4 (RFC4)) and repair (XRCC1 and DNA ligase III).  Of these, only RFC4 was a repeated result. 






   Our work represents the first studies of the biological roles of mcph1 using a genetic  model  system,  Drosophila  melanogaster.    We  identified  a  developmental requirement for the protein during the earliest stages of Drosophila embryogenesis and further found that the Anaphase Promoting Complex (APC) regulates its levels.  We also identified many potential new proteins in complex with MCPH1 in an effort to  understand  the  mechanism  by  which  MCPH1  controls  cell‐cycle  progression.  Based upon our conclusions, we now propose further studies.   Our screen for interactors of MCPH1 revealed several new possible pathways in which MCPH1 might participate.  Quite surprisingly, this includes a potential role in heterochromatin silencing.   The Drosophila model system was the first in which position  effect  variegation  was  studied.    This  term  simply  describes  the phenomenon  in  which  the  condensed  state  of  the  chromatin  affects  gene transcription.  Genes located in less condensed euchromatin are easily transcribed.  On  the  contrary,  genes  that  may  have  translocated  to  highly  condensed heterochromatin  are  not  expressed  due  to  the  limited  access  to  the  region  by transcription factors and polymerases.  Altering the state of the chromatin can allow transcription of masked genes.  Mutation of Argonaute 2, a core component of siRNA silencing  required  for  heterochromatin  silencing  in  the  early  Drosophila  embryo, leads  to  decondensed  chromatin  at  the  centromere.  This  prevents  CID,  a 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centromeric  protein  marker  and  histone  H3  variant,  from  localizing  to  the centromere  in argonaute 2 mutants  (Deshpande et  al.,  2005).   As  a  result,  defects such  as  chromatin bridging  and  floating  centrosomes  are present,  similar  to what occurs  in mcph1 mutant  embryos  (Deshpande et  al.,  2005; Rickmyre et  al.,  2007).  Suppressor  of  Variegation  3‐7  is  also  required  for  heterochromatin  silencing.  Expression  of  the  white  gene  inserted  into  heterochromatin  is  masked  again  by increasing  doses  of  Su(var)3­7  (Bushey  and  Locke,  2004).  Both  Argonaute2  and Su(var)3‐7 are necessary for promoting heterochromatin formation and were found to  interact  with  MCPH1  in  our  TAP  screen.  It  will  be  interesting  to  determine  if MCPH1 also affects the state of the chromatin.   As described in Chapter 3, human MCPH1 is never fully degraded when the APC is active.  In comparison, Cyclin B is quickly and fully degraded (See Figure 3.B).  This raises questions as to how APC might order the destruction of MCPH1.  A study by  Rape  et  al.  (2008)  suggested  that  different  APC  substrates  could  be  processed differently.  Some are polyubiquitylated for degradation after only binding to APC a few  times,  and  others,  known  as  distributive  substrates,  are  out‐competed  for binding and therefore take longer to be recognized by the 26S proteasome.   It was also suggested that the distributive substrates are further deubiquitylated by DUBs (deubiquitinating  enzymes).    Because  human  MCPH1  participates  in  the  DNA damage response, it makes sense that the protein is never fully degraded during G1.  It will be interesting to determine the processivity of APC on MCPH1 and if there is a DUB further preventing full degradation by the proteasome. 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 Finally, mutation of MCPH1 in humans is responsible for autosomal recessive primary microcephaly, a disorder of brain development.  The first vertebrate models with  mutation  of  MCPH1,  which  were  published  this  year,  have  only  confirmed results  from  cell  culture  studies  that MCPH1  is  required  for  the  response  to DNA damage  (Liang  et  al.,  2010)  and  to  prevent  premature  chromosome  condensation (Trimborn et  al.,  2010).    In  addition, we  showed  that  a null mutation of mcph1  in Drosophila  leads  to  defects  in  the  mushroom  bodies,  the  learning  and  memory center of  the adult  fly brain  (See Figure 2.11). To date, no study has attempted  to understand  the  role  of  MCPH1  in  brain  development  using  a  vertebrate  model system.    We  propose  to  use  the  Xenopus  embryo,  a  model  that  has  been  used extensively  to  understand  neurulation,  in  order  to  study  the  effects  of  MCPH1 knockdown by morpholino injection on vertebrate brain development.  Preliminary studies from a graduate student collaborator from Marc Kirschner’s lab, Danny Ooi, suggest  that  loss  of MCPH1  leads  to  smaller  brains,  similar  to what  occurs  in  the human disorder.   MCPH1  transcripts  are  highly  expressed  in  neural  tissues  of  the developing  Xenopus  embryo  (Figure  5.1A).      Injection  of  morpholinos  against 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